PG.ProteinGroups,PG.Genes,short.name,GO,sub.cell,description,GO.ID,ConditionNorm_P_0_1,ConditionNorm_P_0_2,ConditionNorm_P_0_3,ConditionNorm_P_300_1,ConditionNorm_P_300_2,ConditionNorm_P_300_3,median,Log2,logFC,AveExpr,t,P.Value,adj.P.Val,B,mass,neglog.adj.P.Val.,TotalPeptidesOverallInGene,P0_Undetected,P300_Undetected,medians_.ConditionNorm_P_0_1_ConditionNorm_P_0_2_ConditionNorm_P_0_3,medians_.ConditionNorm_P_300_1_ConditionNorm_P_300_2_ConditionNorm_P_300_3,Ratio,Ratio_log2,ConditionNorm_P_300_1_log2,ConditionNorm_P_300_2_log2,ConditionNorm_P_300_3_log2,lamp
Q13011,ECH1,ECH1_HUMAN,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; isomerase activity [GO:0016853]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation [GO:0006635]; protein targeting to peroxisome [GO:0006625],SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}. Peroxisome {ECO:0000250}.,"Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (EC 5.3.3.-)",GO:0005102; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0016020; GO:0016853; GO:0070062,1.00E-07,1.00E-07,1.00E-07,0.01032394,0.010472199,0.010426498,0.010426498,-6.583601474,0.010407446,0.005203823,152.6266733,3.17E-09,9.03E-06,11.97384597,35816,5.04426925,10,3,0,1.00E-07,0.010426498,104264.983,16.66989519,-6.597862508,-6.577291813,-6.583601474,1
Q8IWV8,UBR2,UBR2_HUMAN,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Associated with chromatin during meiosis.,E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II),GO:0000151; GO:0000209; GO:0000785; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006342; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596,8.03E-05,0.000112369,9.97E-05,0.06949141,0.068655102,0.071311948,0.06949141,-3.847021535,0.069722024,0.034958475,92.13306878,2.80E-08,4.63E-05,9.324880597,200538,4.33417922,16,0,0,9.97E-05,0.06949141,696.6975226,9.444388623,-3.847021535,-3.864489244,-3.809712368,1
P61086,UBE2K,UBE2K_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium tip [GO:0032433]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P61085}.,Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase),GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0010800; GO:0010994; GO:0016567; GO:0031625; GO:0032433; GO:0032434; GO:0034450; GO:0035458; GO:0043161; GO:0060340; GO:0070059; GO:0070936,0.003435973,0.001661414,0.003380356,0.071323016,0.071929898,0.074247193,0.071929898,-3.797264626,0.069674122,0.037662975,67.9202435,1.04E-07,8.12E-05,7.713510661,22407,4.090477875,6,0,0,0.003380356,0.071929898,21.27879175,4.411344329,-3.809488479,-3.797264626,-3.751519698,1
P46109,CRKL,CRKL_HUMAN,cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; RNA binding [GO:0003723]; SH3/SH2 adaptor activity [GO:0005070]; activation of MAPKK activity [GO:0000186]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; cytokine-mediated signaling pathway [GO:0019221]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; parathyroid gland development [GO:0060017]; positive regulation of cell proliferation [GO:0008284]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Ras protein signal transduction [GO:0007265]; thymus development [GO:0048538],,Crk-like protein,GO:0000186; GO:0001568; GO:0001784; GO:0003723; GO:0005070; GO:0005654; GO:0005768; GO:0005829; GO:0007254; GO:0007265; GO:0007507; GO:0008284; GO:0009887; GO:0009952; GO:0019221; GO:0035556; GO:0042802; GO:0045296; GO:0048538; GO:0060017; GO:1900026,3.01E-06,3.39E-05,0.000224122,0.012640419,0.013170416,0.012358906,0.012640419,-6.30581186,0.012636232,0.006405131,51.7115075,3.38E-07,0.000222764,6.269725487,33777,3.652155689,11,0,0,3.39E-05,0.012640419,372.7490473,8.542060855,-6.30581186,-6.246555235,-6.338305109,1
Q9BQ39,DDX50,DDX50_HUMAN,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; RNA secondary structure unwinding [GO:0010501],"SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849}.",ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2),GO:0003723; GO:0004004; GO:0005524; GO:0005730; GO:0005737; GO:0005886; GO:0010501; GO:0016020,0.00010973,6.36E-05,7.13E-05,0.020161018,0.019940545,0.022158974,0.020161018,-5.63228768,0.020671961,0.010417532,30.3416371,3.36E-06,0.000806895,3.446256808,82565,3.093182777,7,0,0,7.13E-05,0.020161018,282.6492277,8.142868945,-5.63228768,-5.648151377,-5.495965083,1
Q9UIC8,LCMT1,LCMT1_HUMAN,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; C-terminal protein methylation [GO:0006481]; cellular protein modification process [GO:0006464]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein complex assembly [GO:0031333]; protein methylation [GO:0006479]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266],,Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1),GO:0000086; GO:0003880; GO:0005654; GO:0005829; GO:0006464; GO:0006479; GO:0006481; GO:0008757; GO:0010906; GO:0018423; GO:0031333; GO:0042981; GO:0090266,0.000880449,0.000114683,0.000258596,0.011726148,0.011948583,0.010778687,0.011726148,-6.414127016,0.011066563,0.005951191,26.5941464,5.93E-06,0.001208663,2.74932312,38379,2.917694887,9,0,0,0.000258596,0.011726148,45.34538744,5.502883901,-6.414127016,-6.387016624,-6.535674782,1
P36578,RPL4,RL4_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]",,60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4),GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005791; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0022625; GO:0070062; GO:1990904,0.000389137,0.000422111,0.000275745,0.005995715,0.005670522,0.005286306,0.005670522,-7.462302786,0.005288516,0.003006589,25.3211692,7.32E-06,0.001457452,2.490251186,47697,2.836405674,17,0,0,0.000389137,0.005670522,14.57203608,3.865130567,-7.381852478,-7.462302786,-7.563524478,1
O94921,CDK14,CDK14_HUMAN,cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055],SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein. Cytoplasm. Nucleus. Note=Recruited to the cell membrane by CCNY.,Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1) (hPFTAIRE1),GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016055; GO:0030332; GO:0051301; GO:0060828,3.84E-05,3.65E-05,2.48E-05,0.054702461,0.063197012,0.059455454,0.059455454,-4.072047034,0.059085106,0.029575756,24.9717118,7.77E-06,0.00146855,2.416877513,53057,2.833111397,5,0,0,3.65E-05,0.059455454,1630.727085,10.67129964,-4.192250453,-3.983999838,-4.072047034,1
Q06455,RUNX1T1,MTG8_HUMAN,"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; generation of precursor metabolites and energy [GO:0006091]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00440, ECO:0000269|PubMed:10973986}. Note=Colocalizes with ATN1 in discrete nuclear dots.",Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2),GO:0003677; GO:0003700; GO:0003714; GO:0005654; GO:0006091; GO:0006351; GO:0016363; GO:0045599; GO:0045892; GO:0046872,1.00E-07,1.00E-07,1.00E-07,0.561850997,0.586033555,0.501220312,0.561850997,-0.831740516,0.549701521,0.274850861,22.64312453,1.18E-05,0.001777227,1.900443626,67566,2.750257219,4,3,0,1.00E-07,0.561850997,5618509.973,22.42175615,-0.831740516,-0.770944821,-0.996483214,1
Q2V2M9,FHOD3,FHOD3_HUMAN,striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament network formation [GO:0051639]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:21149568}. Note=Main part of the protein localizes to actin fibers and the remaining part displays filamentous staining. {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 4: Cytoplasm, myofibril, sarcomere, Z line. Note=Threonine phosphorylation in isoform 4-specific sequence TDTDEEEEVE is required for targeting to myofibrils in cardiomyocytes.",FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2),GO:0003779; GO:0005865; GO:0030018; GO:0030837; GO:0045214; GO:0051639; GO:0055003,5.25E-05,0.000197131,0.000104553,0.168128054,0.176062522,0.148165608,0.168128054,-2.57236762,0.164000674,0.082118391,20.53361017,1.80E-05,0.00223134,1.385305343,158613,2.651434302,14,0,0,0.000104553,0.168128054,1608.069163,10.65111374,-2.57236762,-2.505840254,-2.754717485,1
Q96A35,MRPL24,RM24_HUMAN,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412],"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:25278503, ECO:0000269|PubMed:25838379}.","39S ribosomal protein L24, mitochondrial (L24mt) (MRP-L24) (Mitochondrial large ribosomal subunit protein uL24m)",GO:0003735; GO:0005743; GO:0005762; GO:0006412; GO:0070125; GO:0070126,8.71E-05,0.000210684,0.001530547,0.039165155,0.038424241,0.044878986,0.039165155,-4.674285518,0.040213366,0.020716111,19.97639402,2.02E-05,0.002249439,1.240552159,24915,2.647925761,5,0,0,0.000210684,0.039165155,185.8954116,7.538347351,-4.674285518,-4.701839411,-4.477816112,1
P63244,RACK1,RACK1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; IRE1-RACK1-PP2A complex [GO:1990630]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935]; cadherin binding [GO:0045296]; cyclin binding [GO:0030332]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase inhibitor activity [GO:0030292]; protein-containing complex scaffold activity [GO:0032947]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell cycle [GO:0007049]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cAMP catabolic process [GO:0030822]; positive regulation of cell migration [GO:0030335]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]; viral process [GO:0016032],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11312657, ECO:0000269|PubMed:17956333}; Peripheral membrane protein. Cytoplasm {ECO:0000269|PubMed:10849009, ECO:0000269|PubMed:11279199, ECO:0000269|PubMed:12958311, ECO:0000269|PubMed:19785988, ECO:0000269|PubMed:20499158, ECO:0000269|PubMed:20573744}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:11279199, ECO:0000269|PubMed:12958311}. Nucleus {ECO:0000269|PubMed:10849009}. Perikaryon {ECO:0000250|UniProtKB:P68040}. Cell projection, dendrite {ECO:0000250|UniProtKB:P68040}. Cell projection, phagocytic cup {ECO:0000269|PubMed:21347310}. Note=Recruited to the plasma membrane through interaction with KRT1 which binds to membrane-bound ITGB1 (PubMed:17956333). Also associated with the membrane in oncogene-transformed cells (PubMed:11884618). PKC activation induces translocation from the perinuclear region to the cell periphery (PubMed:11279199). In the brain, detected mainly in cell bodies and dendrites with little expression in axonal fibers or nuclei (By similarity). Localized to phagocytic cups following infection by Y.pestis (PubMed:21347310). {ECO:0000250|UniProtKB:P68040, ECO:0000269|PubMed:11279199, ECO:0000269|PubMed:11884618, ECO:0000269|PubMed:17956333, ECO:0000269|PubMed:21347310}.","Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]",GO:0001891; GO:0001934; GO:0003723; GO:0005080; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006919; GO:0007049; GO:0007369; GO:0008200; GO:0008656; GO:0010629; GO:0010803; GO:0015935; GO:0016032; GO:0016567; GO:0017148; GO:0019899; GO:0019903; GO:0030178; GO:0030292; GO:0030308; GO:0030332; GO:0030335; GO:0030425; GO:0030496; GO:0030822; GO:0030971; GO:0032436; GO:0032464; GO:0032880; GO:0032947; GO:0033137; GO:0035591; GO:0042169; GO:0042803; GO:0042998; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043473; GO:0043547; GO:0045296; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051343; GO:0051726; GO:0051898; GO:0051901; GO:0070062; GO:0071333; GO:0071363; GO:0072344; GO:1900102; GO:1903208; GO:1990630; GO:2000114; GO:2000304; GO:2000543; GO:2001244,3.71E-05,0.000156408,1.00E-07,0.02122071,0.017823201,0.020656747,0.020656747,-5.59724311,0.019835684,0.009982377,19.56037456,2.21E-05,0.00242986,1.129876894,35077,2.614418747,11,1,0,3.71E-05,0.020656747,556.8029467,9.121023036,-5.558383242,-5.810099753,-5.59724311,1
O96005,CLPTM1,CLPT1_HUMAN,external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,Cleft lip and palate transmembrane protein 1,GO:0005887; GO:0007275; GO:0009897; GO:0016020; GO:0030154; GO:0033081,0.000446398,0.000231643,0.000256703,0.010824544,0.009206865,0.010795883,0.010795883,-6.533374877,0.009964183,0.005293673,19.11470814,2.44E-05,0.002555236,1.008729949,76097,2.592568962,7,0,0,0.000256703,0.010795883,42.05588429,5.394235766,-6.529549929,-6.763074229,-6.533374877,1
O76070,SNCG,SYUG_HUMAN,axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; protein secretion [GO:0009306]; regulation of dopamine secretion [GO:0014059]; regulation of neurotransmitter secretion [GO:0046928]; synapse organization [GO:0050808],"SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:11746666}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:11746666}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:11746666}. Note=Associated with centrosomes in several interphase cells. In mitotic cells, localized to the poles of the spindle.",Gamma-synuclein (Breast cancer-specific gene 1 protein) (Persyn) (Synoretin) (SR),GO:0005737; GO:0005815; GO:0005819; GO:0007268; GO:0008344; GO:0009306; GO:0014059; GO:0030424; GO:0043025; GO:0046928; GO:0048471; GO:0050808; GO:0070062,1.00E-07,1.00E-07,1.00E-07,0.002047474,0.001746872,0.001813626,0.001813626,-9.106907343,0.001869224,0.000934712,18.18767097,3.02E-05,0.002903462,0.747634691,13331,2.537083906,6,3,0,1.00E-07,0.001813626,18136.25954,14.14658932,-8.931939021,-9.161010471,-9.106907343,1
Q9BY67,CADM1,CADM1_HUMAN,basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; adherens junction organization [GO:0034332]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; multicellular organism development [GO:0007275]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11279526, ECO:0000269|PubMed:22438059}; Single-pass type I membrane protein {ECO:0000269|PubMed:11279526}. Cell junction, synapse {ECO:0000250|UniProtKB:Q8R5M8}. Note=Localized to the basolateral plasma membrane of epithelial cells in gall bladder. {ECO:0000250|UniProtKB:Q8R5M8}.",Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1),GO:0002376; GO:0005102; GO:0005886; GO:0005887; GO:0005911; GO:0005913; GO:0006915; GO:0007156; GO:0007157; GO:0007275; GO:0007283; GO:0008037; GO:0016323; GO:0030154; GO:0030165; GO:0034332; GO:0042271; GO:0042803; GO:0045202; GO:0045954; GO:0050715; GO:0050839; GO:0051606,1.00E-07,1.00E-07,0.000172772,0.064056438,0.057836358,0.052546916,0.057836358,-4.111879492,0.058088913,0.029102114,18.14194905,3.05E-05,0.002903462,0.734423675,48509,2.537083906,6,2,0,1.00E-07,0.057836358,578363.5763,19.14161717,-3.96451261,-4.111879492,-4.250250089,1
Q53FT3,HIKESHI,HIKES_HUMAN,cytosol [GO:0005829]; intracellular [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; protein transporter activity [GO:0008565]; cellular response to heat [GO:0034605]; Golgi organization [GO:0007030]; lung development [GO:0030324]; protein import into nucleus [GO:0006606]; protein transport [GO:0015031]; regulation of cellular response to heat [GO:1900034],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9DD02}. Cytoplasm, cytosol {ECO:0000269|PubMed:22541429}. Nucleus {ECO:0000269|PubMed:22541429}.",Protein Hikeshi,GO:0005622; GO:0005634; GO:0005654; GO:0005829; GO:0006606; GO:0007030; GO:0008565; GO:0015031; GO:0030324; GO:0030544; GO:0034605; GO:1900034,3.39E-05,3.07E-05,6.18E-05,0.042957993,0.03876629,0.034927181,0.03876629,-4.689053522,0.038841708,0.019462967,17.39870251,3.65E-05,0.003095217,0.514995312,21628,2.509308903,3,0,0,3.39E-05,0.03876629,1144.789962,10.16086721,-4.540929585,-4.689053522,-4.839505975,1
Q6P1Q0,LETMD1,LTMD1_HUMAN,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribosome binding [GO:0043022]; cellular metal ion homeostasis [GO:0006875],"SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:17943721, ECO:0000269|PubMed:18045496}; Single-pass membrane protein {ECO:0000269|PubMed:17943721, ECO:0000269|PubMed:18045496}.",LETM1 domain-containing protein 1 (Cervical cancer 1 proto-oncogene protein p40) (Cervical cancer proto-oncogene 2 protein) (HCCR-1) (HCRR-2),GO:0005654; GO:0005739; GO:0005741; GO:0005743; GO:0006875; GO:0016021; GO:0043022,1.25E-05,7.73E-06,7.69E-07,0.018972044,0.020297671,0.016468865,0.018972044,-5.719981069,0.018572511,0.009293271,17.17029456,3.86E-05,0.00324266,0.445727861,41790,2.489098611,4,0,0,7.73E-06,0.018972044,2453.570421,11.26066696,-5.719981069,-5.622542018,-5.924115041,1
Q5VTB9,RNF220,RN220_HUMAN,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q6PDX6}.,E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220),GO:0004842; GO:0005737; GO:0016567; GO:0046872; GO:0051865; GO:0061630; GO:0090263,0.011031117,0.000555546,0.000685635,0.084632554,0.078180001,0.090035429,0.084632554,-3.562643486,0.080191896,0.044186714,17.08404455,3.95E-05,0.003274863,0.419338357,62765,2.484806917,8,0,0,0.000685635,0.084632554,123.4367433,6.947628093,-3.562643486,-3.677056586,-3.473363374,1
P09104,ENO2,ENOG_HUMAN,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; myelin sheath [GO:0043209]; perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Can translocate to the plasma membrane in either the homodimeric (alpha/alpha) or heterodimeric (alpha/gamma) form. {ECO:0000250}.,Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase) (NSE),GO:0000015; GO:0000287; GO:0001917; GO:0004634; GO:0005615; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0016020; GO:0043204; GO:0043209; GO:0061621; GO:0070062,1.00E-07,3.43E-06,1.00E-07,0.024091482,0.023583945,0.019694302,0.023583945,-5.406051101,0.022455368,0.011228893,16.78651537,4.26E-05,0.003394233,0.327301176,47269,2.469258311,17,2,0,1.00E-07,0.023583945,235839.4538,17.84744556,-5.375333041,-5.406051101,-5.666077902,1
O95071,UBR5,UBR5_HUMAN,"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cell proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus, translocation [GO:0033160]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]",SUBCELLULAR LOCATION: Nucleus.,"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)",GO:0000209; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0008283; GO:0010628; GO:0016020; GO:0032991; GO:0033160; GO:0034450; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000780,6.53E-05,9.80E-05,0.00728889,0.100290089,0.101523143,0.085079787,0.100290089,-3.317749052,0.093146938,0.049057537,16.66455082,4.39E-05,0.003447067,0.289114541,309352,2.462550315,23,0,0,9.80E-05,0.100290089,1023.006011,9.998598907,-3.317749052,-3.300119457,-3.555039767,1
Q9UPN6,SCAF8,SCAF8_HUMAN,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],SUBCELLULAR LOCATION: Nucleus. Nucleus matrix. Note=Detected in granular nuclear foci which correspond to sites of active transcription. {ECO:0000250}.,Protein SCAF8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16) (SR-related and CTD-associated factor 8),GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380; GO:0016363; GO:0043175,0.00195358,0.001459304,0.006965632,0.196750268,0.238003198,0.200730524,0.200730524,-2.316668077,0.208368492,0.107643751,16.33425602,4.78E-05,0.003567309,0.184323639,140519,2.447659305,10,0,0,0.00195358,0.200730524,102.7500949,6.682995917,-2.345562492,-2.070947135,-2.316668077,1
P31930,UQCRC1,QCR1_HUMAN,"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; protein processing [GO:0016485]; response to activity [GO:0014823]; response to alkaloid [GO:0043279]",SUBCELLULAR LOCATION: Mitochondrion inner membrane.,"Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)",GO:0004222; GO:0005739; GO:0005743; GO:0005746; GO:0005750; GO:0005829; GO:0006119; GO:0006122; GO:0008121; GO:0008270; GO:0009060; GO:0014823; GO:0016485; GO:0031625; GO:0043209; GO:0043279; GO:0044877; GO:0055114,0.002102451,0.002036653,0.002325711,0.019833868,0.021201081,0.024058869,0.021201081,-5.559718366,0.019543001,0.011926439,16.25856097,4.88E-05,0.003567309,0.160019197,52646,2.447659305,10,0,0,0.002102451,0.021201081,10.08398138,3.333993455,-5.655890099,-5.559718366,-5.377287396,1
P30040,ERP29,ERP29_HUMAN,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein folding [GO:0006457]; protein secretion [GO:0009306]; protein unfolding [GO:0043335]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235],SUBCELLULAR LOCATION: Endoplasmic reticulum lumen. Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.,Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31),GO:0000187; GO:0001934; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0030133; GO:0042470; GO:0042803; GO:0043335; GO:0050709; GO:0051087; GO:1902235,1.00E-07,1.00E-07,1.00E-07,0.042625773,0.041187691,0.03399006,0.041187691,-4.601642936,0.039267741,0.019633971,15.27100277,6.37E-05,0.004274369,-0.167505816,28993,2.369127968,7,3,0,1.00E-07,0.041187691,411876.911,18.65185373,-4.5521302,-4.601642936,-4.878743287,1
O95996,APC2,APCL_HUMAN,actin filament [GO:0005884]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; lamellipodium membrane [GO:0031258]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; beta-catenin binding [GO:0008013]; microtubule binding [GO:0008017]; activation of GTPase activity [GO:0090630]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:10644998, ECO:0000269|PubMed:11691822, ECO:0000269|PubMed:25753423}. Golgi apparatus {ECO:0000269|PubMed:11691822}. Cytoplasm {ECO:0000269|PubMed:11691822}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:10646860}. Note=Associated with actin filaments (PubMed:11691822, PubMed:25753423). Associated with microtubule network (PubMed:10644998, PubMed:11691822, PubMed:25753423). {ECO:0000269|PubMed:10644998, ECO:0000269|PubMed:11691822, ECO:0000269|PubMed:25753423}.",Adenomatous polyposis coli protein 2 (Adenomatous polyposis coli protein-like) (APC-like),GO:0000226; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005884; GO:0008013; GO:0008017; GO:0015630; GO:0016055; GO:0016342; GO:0030496; GO:0031258; GO:0045171; GO:0048471; GO:0090090; GO:0090630,2.08E-05,2.62E-05,3.36E-05,0.231964314,0.205074597,0.182124622,0.205074597,-2.285779301,0.206360977,0.103207356,14.8882503,7.09E-05,0.004564371,-0.299972785,243949,2.340619023,20,0,0,2.62E-05,0.205074597,7826.80279,12.93420738,-2.108025221,-2.285779301,-2.457002115,1
O43405,COCH,COCH_HUMAN,extracellular matrix [GO:0031012]; collagen binding [GO:0005518]; defense response to bacterium [GO:0042742]; positive regulation of innate immune response [GO:0045089]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:12843317, ECO:0000269|PubMed:22610276}.",Cochlin (COCH-5B2),GO:0005518; GO:0007605; GO:0008360; GO:0031012; GO:0042742; GO:0045089,1.00E-07,1.00E-07,1.29E-06,0.239087461,0.244283354,0.296967736,0.244283354,-2.033372537,0.260112354,0.130056673,14.6189403,7.66E-05,0.004859334,-0.395157398,59483,2.313423234,3,2,0,1.00E-07,0.244283354,2442833.539,21.22012413,-2.064389624,-2.033372537,-1.751621895,1
Q9NZV5,SELENON,SELN_HUMAN,endoplasmic reticulum membrane [GO:0005789]; calcium ion binding [GO:0005509]; oxidoreductase activity [GO:0016491]; calcium ion homeostasis [GO:0055074]; positive regulation of response to oxidative stress [GO:1902884]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; skeletal muscle fiber development [GO:0048741],SUBCELLULAR LOCATION: Isoform 2: Endoplasmic reticulum membrane {ECO:0000269|PubMed:12700173}.,Selenoprotein N (SelN),GO:0005509; GO:0005789; GO:0016491; GO:0048741; GO:0055074; GO:0060314; GO:1902884,0.016702248,0.021769363,0.020448095,0.129368557,0.142860759,0.115400628,0.129368557,-2.950441077,0.10957008,0.074424942,14.10551132,8.92E-05,0.005193901,-0.581383005,65813,2.284506339,6,0,0,0.020448095,0.129368557,6.326680224,2.661448678,-2.950441077,-2.807318406,-3.115277014,1
P46379,BAG6,BAG6_HUMAN,BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; embryo development [GO:0009790]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; proteasomal protein catabolic process [GO:0010498]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein stabilization [GO:0050821]; regulation of cell proliferation [GO:0042127]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:29042515}. Nucleus {ECO:0000269|PubMed:14960581, ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:29042515}. Secreted, exosome {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879}. Note=Normally localized in cytosol and nucleus, it can also be released extracellularly, in exosomes, by tumor and myeloid dendritic cells (PubMed:18055229, PubMed:18852879). Cytoplasmic retention is due to interaction with GET4 (PubMed:29042515). {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879, ECO:0000269|PubMed:29042515}.",Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0009790; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030433; GO:0030544; GO:0031593; GO:0031625; GO:0032435; GO:0042127; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043231; GO:0045861; GO:0050821; GO:0051787; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071712; GO:0071816; GO:0071818; GO:1904294; GO:1904378; GO:1904379; GO:1990381,0.000161111,0.00845759,7.57E-05,0.106838196,0.131762476,0.133967391,0.131762476,-2.923988519,0.121291217,0.063543746,13.80061951,9.79E-05,0.005584156,-0.695068636,119409,2.25304246,20,0,0,0.000161111,0.131762476,817.8380642,9.675671401,-3.226500572,-2.923988519,-2.900046221,1
Q01484,ANK2,ANK2_HUMAN,"A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; intracellular [GO:0005622]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; ER to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:19007774}. Membrane {ECO:0000269|PubMed:19007774}. Cytoplasm, myofibril, sarcomere, M line {ECO:0000250|UniProtKB:Q8C8R3}. Apical cell membrane {ECO:0000250|UniProtKB:Q8C8R3}. Cell membrane {ECO:0000269|PubMed:19007774}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250|UniProtKB:Q8C8R3}. Early endosome {ECO:0000250|UniProtKB:Q8C8R3}. Recycling endosome {ECO:0000250|UniProtKB:Q8C8R3}. Lysosome {ECO:0000250|UniProtKB:Q8C8R3}. Mitochondrion {ECO:0000250|UniProtKB:Q8C8R3}. Note=Expressed at the apical membrane of airway lung epithelial cells (By similarity). Localized to the plasma membrane of the inner segments of photoreceptors in retina. Colocalizes with SPTBN1 in a distinct intracellular compartment of neonatal cardiomyocytes (PubMed:19007774). In skeletal muscle, localizes to neuromuscular junctions (By similarity). Localizes with puncta at mitochondria ends. Colocalizes and cotransports on motile vesicles with RABGAP1L (By similarity). {ECO:0000250|UniProtKB:Q8C8R3, ECO:0000269|PubMed:19007774}.",Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin),GO:0002027; GO:0003283; GO:0005200; GO:0005622; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001259,3.84E-05,2.13E-05,5.81E-05,0.001515711,0.001764166,0.001410359,0.001515711,-9.365789901,0.001524131,0.000801347,13.28464714,0.00011499,0.006076017,-0.893042927,433715,2.21638101,97,0,0,3.84E-05,0.001515711,39.43104753,5.301260133,-9.365789901,-9.146798236,-9.469721564,1
P62241,RPS8,RS8_HUMAN,"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17289661}. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs.,40S ribosomal protein S8 (Small ribosomal subunit protein eS8),GO:0000184; GO:0000462; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0022627; GO:0070062; GO:1990904,1.00E-07,1.00E-07,1.00E-07,0.003964656,0.003210552,0.003135936,0.003210552,-8.282963085,0.003436948,0.001718574,13.2040028,0.000117991,0.006196352,-0.924646218,24205,2.207863897,8,3,0,1.00E-07,0.003210552,32105.51631,14.97053358,-7.978588518,-8.282963085,-8.316887946,1
O15394,NCAM2,NCAM2_HUMAN,axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608],SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein.,Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2),GO:0005886; GO:0007158; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0042802,7.28E-05,0.000113101,0.000128986,0.160688144,0.164282501,0.126910239,0.160688144,-2.637664612,0.150521982,0.07536597,13.13922602,0.000120472,0.006212283,-0.950164618,93046,2.206748771,15,0,0,0.000113101,0.160688144,1420.7483,10.47243527,-2.637664612,-2.605749283,-2.978119631,1
Q9NQG5,RPRD1B,RPR1B_HUMAN,"centrosome [GO:0005813]; cytosol [GO:0005829]; DNA-directed RNA polymerase II, holoenzyme [GO:0016591]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA polymerase II core binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564]; snRNA transcription by RNA polymerase II [GO:0042795]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22264791}.,Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor),GO:0000993; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0008284; GO:0010564; GO:0016591; GO:0042795; GO:0042802; GO:0045944; GO:0070940,1.00E-07,1.00E-07,1.00E-07,0.065219127,0.084692116,0.070439024,0.070439024,-3.827481262,0.073449989,0.036725095,13.1142423,0.000121446,0.006224998,-0.960038796,36900,2.205860796,9,3,0,1.00E-07,0.070439024,704390.2441,19.4260154,-3.938561069,-3.561628507,-3.827481262,1
Q9BX68,HINT2,HINT2_HUMAN,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694],"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16762638, ECO:0000269|PubMed:18653718}.","Histidine triad nucleotide-binding protein 2, mitochondrial (HINT-2) (EC 3.-.-.-) (HINT-3) (HIT-17kDa) (PKCI-1-related HIT protein)",GO:0000166; GO:0005730; GO:0005739; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:2000757,1.00E-07,0.00283488,1.00E-07,0.016635961,0.020205013,0.018276477,0.018276477,-5.773868195,0.017427457,0.009658755,12.93552325,0.000128701,0.006480455,-1.031199109,17162,2.188394515,3,2,0,1.00E-07,0.018276477,182764.7692,17.47962847,-5.90955098,-5.629142936,-5.773868195,1
P07741,APRT,APT_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; cellular response to insulin stimulus [GO:0032869]; grooming behavior [GO:0007625]; lactation [GO:0007595]; neutrophil degranulation [GO:0043312]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101],SUBCELLULAR LOCATION: Cytoplasm.,Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7),GO:0002055; GO:0003999; GO:0005576; GO:0005654; GO:0005737; GO:0005829; GO:0006166; GO:0006168; GO:0007595; GO:0007625; GO:0016208; GO:0032869; GO:0034774; GO:0043101; GO:0043312; GO:0044209; GO:0070062,1.00E-07,1.00E-07,1.00E-07,0.045320277,0.042186679,0.034143963,0.042186679,-4.567068671,0.040550206,0.020275203,12.65743973,0.000141078,0.006861534,-1.14380176,19608,2.163578784,4,3,0,1.00E-07,0.042186679,421866.7893,18.68642799,-4.463699513,-4.567068671,-4.872225686,1
Q09472,EP300,EP300_HUMAN,"chromosome [GO:0005694]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription factor complex [GO:0005667]; acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; androgen receptor binding [GO:0050681]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; peptide butyryltransferase activity [GO:0140065]; peptide N-acetyltransferase activity [GO:0034212]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; pre-mRNA intronic binding [GO:0097157]; protein C-terminus binding [GO:0008022]; protein propionyltransferase activity [GO:0061920]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; STAT family protein binding [GO:0097677]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]; transferase activity, transferring acyl groups [GO:0016746]; zinc ion binding [GO:0008270]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H2B acetylation [GO:0043969]; histone H4 acetylation [GO:0043967]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; megakaryocyte development [GO:0035855]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA binding transcription factor activity [GO:0051091]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12929931}. Nucleus {ECO:0000269|PubMed:12929931, ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:16574662}. Chromosome {ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:25818647}. Note=Localizes to active chromatin: Colocalizes with histone H3 acetylated and/or crotonylated at 'Lys-18' (H3K18ac and H3K18cr, respectively) (PubMed:25818647). In the presence of ALX1 relocalizes from the cytoplasm to the nucleus. Colocalizes with ROCK2 in the nucleus (PubMed:12929931). {ECO:0000269|PubMed:12929931, ECO:0000269|PubMed:25818647}.",Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-),GO:0000122; GO:0000123; GO:0000978; GO:0001047; GO:0001102; GO:0001228; GO:0001666; GO:0001756; GO:0002039; GO:0002223; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0004402; GO:0004468; GO:0005634; GO:0005654; GO:0005667; GO:0005694; GO:0005829; GO:0006283; GO:0006355; GO:0006473; GO:0006475; GO:0006915; GO:0006977; GO:0006990; GO:0007219; GO:0007221; GO:0007399; GO:0007507; GO:0007519; GO:0007623; GO:0008013; GO:0008022; GO:0008134; GO:0008270; GO:0009887; GO:0010506; GO:0010742; GO:0016032; GO:0016407; GO:0016573; GO:0016746; GO:0018076; GO:0018393; GO:0018394; GO:0030183; GO:0030220; GO:0030324; GO:0031490; GO:0031648; GO:0032092; GO:0032460; GO:0032481; GO:0032993; GO:0033613; GO:0034212; GO:0034644; GO:0035257; GO:0035855; GO:0042771; GO:0043627; GO:0043923; GO:0043967; GO:0043969; GO:0045444; GO:0045652; GO:0045747; GO:0045815; GO:0045893; GO:0045944; GO:0050681; GO:0050821; GO:0051091; GO:0051726; GO:0060765; GO:0061418; GO:0061733; GO:0061920; GO:0061921; GO:0090043; GO:0097157; GO:0097677; GO:0140065; GO:0140066; GO:0140067; GO:0140068; GO:0140069; GO:1900034; GO:1901796; GO:1904837,1.00E-07,0.000211135,1.00E-07,0.022772814,0.028128168,0.030849027,0.028128168,-5.151840605,0.027179558,0.013660224,11.8960325,0.00018327,0.007551525,-1.464535462,264161,2.121965321,6,2,0,1.00E-07,0.028128168,281281.6784,18.10165606,-5.456543644,-5.151840605,-5.018631196,1
Q16718,NDUFA5,NDUA5_HUMAN,"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]",SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305|PubMed:12611891}; Peripheral membrane protein {ECO:0000305}; Matrix side {ECO:0000305}.,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (Complex I subunit B13) (Complex I-13kD-B) (CI-13kD-B) (NADH-ubiquinone oxidoreductase 13 kDa-B subunit),GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0032981,0.014817538,0.018806978,0.017491346,0.091970675,0.083652836,0.072566024,0.083652836,-3.579441743,0.065691225,0.049884233,11.88750359,0.000183824,0.007551525,-1.468236687,13459,2.121965321,4,0,0,0.017491346,0.083652836,4.782527198,2.257773173,-3.442682261,-3.579441743,-3.784561955,1
Q76G19,PDZD4,PDZD4_HUMAN,cell cortex [GO:0005938],"SUBCELLULAR LOCATION: Cytoplasm, cell cortex {ECO:0000269|PubMed:15077175}. Note=Mainly localized under the plasma membrane.",PDZ domain-containing protein 4 (PDZ domain-containing RING finger protein 4-like protein),GO:0005938,5.97E-05,6.96E-05,5.44E-05,0.199207289,0.263311714,0.26214259,0.26214259,-1.931576328,0.241492625,0.120807552,11.84990274,0.000186293,0.007557663,-1.484583892,86171,2.121612493,8,0,0,5.97E-05,0.26214259,4390.12322,12.10004572,-2.327657659,-1.92515639,-1.931576328,1
Q9UL46,PSME2,PSME2_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of endopeptidase activity [GO:0010950]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136],,Proteasome activator complex subunit 2 (11S regulator complex subunit beta) (REG-beta) (Activator of multicatalytic protease subunit 2) (Proteasome activator 28 subunit beta) (PA28b) (PA28beta),GO:0000502; GO:0005654; GO:0005737; GO:0005829; GO:0008537; GO:0010950; GO:0016020; GO:0016579; GO:0035722; GO:0042802; GO:0043687; GO:0061133; GO:0061136; GO:0070062; GO:2000045,0.001537264,0.001271933,0.000612453,0.022270429,0.021523619,0.016812335,0.021523619,-5.53793551,0.019061577,0.010671339,11.43959494,0.000216059,0.008483793,-1.66620537,27402,2.071409931,3,0,0,0.001271933,0.021523619,16.92197473,4.08082603,-5.488726845,-5.53793551,-5.894336088,1
Q9Y3I1,FBXO7,FBX7_HUMAN,classical Lewy body [GO:0097414]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cytoplasmic inclusion [GO:0097409]; Lewy body core [GO:1990037]; Lewy body corona [GO:1990038]; Lewy neurite [GO:0097462]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; autophagy of mitochondrion [GO:0000422]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of lymphocyte differentiation [GO:0045620]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of autophagy of mitochondrion [GO:1903599]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]; regulation of locomotion [GO:0040012]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],"SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Mitochondrion. Cytoplasm, cytosol. Note=Predominantly cytoplasmic. A minor proportion is detected in the nucleus. Relocates from the cytosol to depolarized mitochondria.",F-box only protein 7,GO:0000151; GO:0000209; GO:0000422; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006626; GO:0010975; GO:0016567; GO:0019005; GO:0019901; GO:0031625; GO:0031647; GO:0032991; GO:0040012; GO:0043130; GO:0043687; GO:0045620; GO:0045736; GO:0046982; GO:0097409; GO:0097414; GO:0097462; GO:1903204; GO:1903208; GO:1903599; GO:1990037; GO:1990038; GO:2000134,0.001562913,1.32E-05,1.69E-05,0.132555203,0.133018984,0.099252743,0.132555203,-2.915334798,0.12107796,0.061069996,11.24226334,0.000232443,0.008853276,-1.755738153,58503,2.052896014,5,0,0,1.69E-05,0.132555203,7838.954303,12.9364455,-2.915334798,-2.91029594,-3.332749216,1
P54105,CLNS1A,ICLN_HUMAN,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:21081503}. Nucleus {ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:21081503}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:18984161}. Note=A small fraction is also associated with the cytoskeleton (PubMed:18984161).","Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln)) (Chloride ion current inducer protein) (ClCI) (Reticulocyte pICln)",GO:0000387; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0006821; GO:0006884; GO:0034709; GO:0034715; GO:0046982,1.00E-07,1.00E-07,1.00E-07,0.053844116,0.048335228,0.038578785,0.048335228,-4.370781137,0.046919276,0.023459738,10.92257167,0.000262348,0.009382416,-1.90395025,26215,2.027685299,3,3,0,1.00E-07,0.048335228,483352.282,18.88271553,-4.215067496,-4.370781137,-4.696048481,1
P78332,RBM6,RBM6_HUMAN,nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA processing [GO:0006396],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3),GO:0003677; GO:0003723; GO:0005634; GO:0006396,0.000134645,1.00E-07,1.00E-07,0.012131766,0.008886489,0.009688642,0.009688642,-6.689489881,0.010190684,0.00514029,10.82121155,0.0002728,0.009609757,-1.951785892,128644,2.017287598,10,2,0,1.00E-07,0.009688642,96886.4158,16.56400678,-6.365066673,-6.814170736,-6.689489881,1
Q12852,MAP3K12,M3K12_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.,Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25) (Dual leucine zipper bearing kinase) (DLK) (Leucine-zipper protein kinase) (ZPK) (MAPK-upstream kinase) (MUK) (Mixed lineage kinase),GO:0000165; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0016020; GO:0016572; GO:0018105; GO:0018107; GO:0019901; GO:0030426; GO:0035556; GO:0042803; GO:0046777; GO:2000672,1.00E-07,1.00E-07,1.00E-07,0.144188367,0.116037633,0.104770187,0.116037633,-3.107335321,0.121665296,0.060832748,10.78507758,0.000276649,0.00967507,-1.968939599,93219,2.014345892,5,3,0,1.00E-07,0.116037633,1160376.332,20.14616134,-2.793973318,-3.107335321,-3.254699854,1
Q96N64,PWWP2A,PWP2A_HUMAN,nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28645917}.,PWWP domain-containing protein 2A,GO:0003682; GO:0005634; GO:0042393,0.000245236,0.00027751,0.006167401,0.134411939,0.152096493,0.108054442,0.134411939,-2.895266804,0.129290909,0.066875504,10.37704496,0.00032509,0.010702951,-2.166430418,81960,1.970496457,4,0,0,0.00027751,0.134411939,484.3496087,8.919904966,-2.895266804,-2.716941205,-3.21016971,1
Q8IWA4,MFN1,MFN1_HUMAN,integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; outer mitochondrial membrane protein complex [GO:0098799]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTP metabolic process [GO:0046039]; macroautophagy [GO:0016236]; mitochondrial fusion [GO:0008053]; mitochondrial membrane fusion [GO:1990613]; mitochondrion localization [GO:0051646],"SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:12759376, ECO:0000305|PubMed:27920125}; Multi-pass membrane protein {ECO:0000305|PubMed:12759376}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000269|PubMed:11751411}.",Mitofusin-1 (EC 3.6.5.-) (Fzo homolog) (Transmembrane GTPase MFN1),GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0008053; GO:0016021; GO:0016236; GO:0031307; GO:0046039; GO:0051646; GO:0098799; GO:1990613,0.002167381,2.21E-05,2.76E-05,0.056578522,0.061860391,0.043771147,0.056578522,-4.143601705,0.053330986,0.027404527,10.22814288,0.000345318,0.011159507,-2.240291693,84160,1.952354998,10,0,0,2.76E-05,0.056578522,2050.17658,11.00153246,-4.143601705,-4.014840236,-4.513875994,1
Q96SW2,CRBN,CRBN_HUMAN,Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of protein homodimerization activity [GO:0090073]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20223979}. Nucleus {ECO:0000269|PubMed:20223979}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.,Protein cereblon,GO:0005634; GO:0005730; GO:0005737; GO:0016020; GO:0016567; GO:0031464; GO:0032463; GO:0034766; GO:0043161; GO:0046872; GO:0090073,1.00E-07,1.00E-07,0.006105731,0.107393673,0.088290279,0.077082309,0.088290279,-3.501601593,0.088886777,0.046478699,10.17231074,0.000353297,0.011159507,-2.268242238,50546,1.952354998,8,2,0,1.00E-07,0.088290279,882902.7869,19.75189507,-3.219019089,-3.501601593,-3.697456405,1
Q9BRD0,BUD13,BUD13_HUMAN,"nucleus [GO:0005634]; RES complex [GO:0070274]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]",,BUD13 homolog,GO:0000398; GO:0003723; GO:0005634; GO:0070274,0.027879116,0.030400627,0.014018722,0.126880609,0.119109187,0.100368985,0.119109187,-3.069643404,0.091353439,0.069776208,10.12752638,0.000359862,0.011235758,-2.290764275,70521,1.949397614,5,0,0,0.027879116,0.119109187,4.272344435,2.095027961,-2.978456492,-3.069643404,-3.316614561,1
Q2TBE0,CWF19L2,C19L2_HUMAN,,,CWF19-like protein 2,,9.56E-05,9.95E-05,5.72E-05,0.176879409,0.171462174,0.125674799,0.171462174,-2.544037757,0.157921367,0.079044777,10.10384728,0.000363393,0.011270448,-2.302709526,103787,1.948058805,3,0,0,9.56E-05,0.171462174,1792.721188,10.80793542,-2.499161984,-2.544037757,-2.992232708,1
P00441,SOD1,SODC_HUMAN,axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; interleukin-12-mediated signaling pathway [GO:0035722]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; placenta development [GO:0001890]; platelet degranulation [GO:0002576]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein kinase activity [GO:0045859]; regulation of T cell differentiation in thymus [GO:0033081]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; thymus development [GO:0048538]; transmission of nerve impulse [GO:0019226],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19741096}. Mitochondrion {ECO:0000269|PubMed:19741096}. Nucleus {ECO:0000269|PubMed:22496122}. Note=Predominantly cytoplasmic; the pathogenic variants ALS1 Arg-86 and Ala-94 gradually aggregates and accumulates in mitochondria. {ECO:0000269|PubMed:19741096}.,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1),GO:0000187; GO:0000303; GO:0001541; GO:0001819; GO:0001890; GO:0001895; GO:0001975; GO:0002262; GO:0002576; GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005764; GO:0005777; GO:0005829; GO:0006749; GO:0006801; GO:0006879; GO:0007283; GO:0007566; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0032287; GO:0032839; GO:0032930; GO:0032991; GO:0033081; GO:0034465; GO:0034599; GO:0035722; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043085; GO:0043087; GO:0043209; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046620; GO:0046688; GO:0046716; GO:0048365; GO:0048538; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115,0.005806315,0.001648023,0.001426238,0.021062601,0.021694536,0.018090056,0.021062601,-5.569172574,0.017322206,0.011621295,9.95802328,0.000386099,0.011400774,-2.376844167,15936,1.94306566,6,0,0,0.001648023,0.021062601,12.78052479,3.675875172,-5.569172574,-5.526524456,-5.788659345,1
Q9H6U8,ALG9,ALG9_HUMAN,"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,2-mannosyltransferase activity [GO:0000026]; dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052926]; dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052918]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:15148656}; Multi-pass membrane protein {ECO:0000305}.,"Alpha-1,2-mannosyltransferase ALG9 (EC 2.4.1.259) (EC 2.4.1.261) (Asparagine-linked glycosylation protein 9 homolog) (Disrupted in bipolar disorder protein 1) (Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) (Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase)",GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006488; GO:0016020; GO:0016021; GO:0052918; GO:0052926,0.000196416,1.00E-07,1.00E-07,0.046591689,0.041463859,0.032289974,0.041463859,-4.592001791,0.040049635,0.020090356,9.945991946,0.000388048,0.011400774,-2.383005103,69863,1.94306566,8,2,0,1.00E-07,0.041463859,414638.5918,18.66149487,-4.423783568,-4.592001791,-4.952769906,1
P11413,G6PD,G6PD_HUMAN,"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]",,Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49),GO:0004345; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006629; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0016020; GO:0019322; GO:0021762; GO:0032094; GO:0034599; GO:0042802; GO:0042803; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0055114; GO:0061052; GO:0070062; GO:1904879; GO:2000378,0.000209806,0.000292275,0.000155974,0.041804343,0.040913705,0.029701988,0.040913705,-4.611272011,0.037253994,0.018846348,9.939083726,0.000389173,0.011400774,-2.386545712,59257,1.94306566,14,0,0,0.000209806,0.040913705,195.0075487,7.607386162,-4.580203346,-4.611272011,-5.073296707,1
Q9H857,NT5DC2,NT5D2_HUMAN,5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872],,5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-),GO:0008253; GO:0046872,0.00030239,0.000332684,0.000744893,0.067331759,0.07559529,0.051993104,0.067331759,-3.892569036,0.064513395,0.032716687,9.692345531,0.000432104,0.011922736,-2.514504486,60719,1.923624081,10,0,0,0.000332684,0.067331759,202.3897816,7.660992642,-3.892569036,-3.725559845,-4.265535913,1
P62979,RPS27A,RS27A_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; host cell [GO:0043657]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; activation of MAPK activity [GO:0000187]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular protein metabolic process [GO:0044267]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response, detection of DNA damage [GO:0042769]; endosomal transport [GO:0016197]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; global genome nucleotide-excision repair [GO:0070911]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; interleukin-1-mediated signaling pathway [GO:0070498]; interstrand cross-link repair [GO:0036297]; intracellular transport of virus [GO:0075733]; JNK cascade [GO:0007254]; membrane organization [GO:0061024]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; stress-activated MAPK cascade [GO:0051403]; transcription-coupled nucleotide-excision repair [GO:0006283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; translation [GO:0006412]; translational initiation [GO:0006413]; translesion synthesis [GO:0019985]; transmembrane transport [GO:0055085]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; viral life cycle [GO:0019058]; virion assembly [GO:0019068]; Wnt signaling pathway [GO:0016055]",SUBCELLULAR LOCATION: Ubiquitin: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.,Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; 40S ribosomal protein S27a (Small ribosomal subunit protein eS31)],GO:0000122; GO:0000184; GO:0000187; GO:0000209; GO:0000715; GO:0002755; GO:0003723; GO:0003735; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005741; GO:0005789; GO:0005829; GO:0005886; GO:0006283; GO:0006294; GO:0006296; GO:0006297; GO:0006412; GO:0006413; GO:0006614; GO:0006625; GO:0007179; GO:0007249; GO:0007254; GO:0010008; GO:0015935; GO:0016020; GO:0016055; GO:0016197; GO:0016567; GO:0016579; GO:0019058; GO:0019068; GO:0019221; GO:0019985; GO:0022627; GO:0030512; GO:0030666; GO:0031145; GO:0031982; GO:0033683; GO:0035666; GO:0036297; GO:0042276; GO:0042769; GO:0043065; GO:0043066; GO:0043209; GO:0043488; GO:0043657; GO:0044267; GO:0045944; GO:0046872; GO:0051092; GO:0051403; GO:0055085; GO:0061024; GO:0061418; GO:0070062; GO:0070423; GO:0070498; GO:0070911; GO:0070987; GO:0075733,0.002026324,0.054816576,0.001042738,0.19476001,0.190514737,0.216566223,0.19476001,-2.360230617,0.181318444,0.109954435,9.656857373,0.000438746,0.011922736,-2.53315291,17965,1.923624081,4,0,0,0.002026324,0.19476001,96.11496106,6.58668911,-2.360230617,-2.392025498,-2.207119845,1
P47756,CAPZB,CAPZB_HUMAN,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; F-actin capping protein complex [GO:0008290]; sarcomere [GO:0030017]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; actin cytoskeleton organization [GO:0030036]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; barbed-end actin filament capping [GO:0051016]; blood coagulation [GO:0007596]; cytoskeleton organization [GO:0007010]; ER to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasm, myofibril, sarcomere {ECO:0000250}.",F-actin-capping protein subunit beta (CapZ beta),GO:0003779; GO:0005829; GO:0005856; GO:0005884; GO:0006888; GO:0007010; GO:0007596; GO:0008290; GO:0010591; GO:0015629; GO:0019886; GO:0022604; GO:0030017; GO:0030036; GO:0045296; GO:0051015; GO:0051016; GO:0051490; GO:0070062; GO:0071203,9.25E-05,0.00051826,6.03E-05,0.060715328,0.059537714,0.042573476,0.059537714,-4.070052354,0.054051804,0.027249604,9.579566753,0.000453647,0.012249913,-2.573984932,31350,1.911866993,15,0,0,9.25E-05,0.059537714,643.4611843,9.329709313,-4.041795403,-4.070052354,-4.55390131,1
Q9BYP7,WNK3,WNK3_HUMAN,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16501604}.,Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3),GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005912; GO:0005923; GO:0006468; GO:0010765; GO:0010800; GO:0019869; GO:0032414; GO:0035556; GO:0043066; GO:0046777; GO:0050801; GO:0051928; GO:0072659; GO:0090188; GO:0090279; GO:1903078; GO:2000651,2.86E-06,0.000361658,1.00E-07,0.061943735,0.066810604,0.045840555,0.061943735,-4.012897823,0.058076759,0.029159918,9.521562945,0.000465239,0.012445135,-2.604825354,198416,1.905000376,20,1,0,2.86E-06,0.061943735,21673.7328,14.40366003,-4.012897823,-3.903779078,-4.447231672,1
O95487,SEC24B,SC24B_HUMAN,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cargo loading into COPII-coated vesicle [GO:0090110]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; coronary artery morphogenesis [GO:0060982]; ER to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178],"SUBCELLULAR LOCATION: Cytoplasmic vesicle, COPII-coated vesicle membrane {ECO:0000269|PubMed:10075675}; Peripheral membrane protein {ECO:0000305|PubMed:10075675}; Cytoplasmic side {ECO:0000305|PubMed:10075675}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:10075675}; Peripheral membrane protein {ECO:0000269|PubMed:10075675}; Cytoplasmic side {ECO:0000269|PubMed:10075675}. Cytoplasm, cytosol {ECO:0000269|PubMed:10075675}.",Protein transport protein Sec24B (SEC24-related protein B),GO:0000139; GO:0001843; GO:0002474; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0021747; GO:0030127; GO:0035909; GO:0048208; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0090110; GO:0090178; GO:1901301,2.29E-05,4.20E-05,3.76E-05,0.019654522,0.029062841,0.024756068,0.024756068,-5.336074014,0.024456983,0.012262652,9.343927374,0.00050306,0.013209189,-2.700346877,137418,1.879123841,18,0,0,3.76E-05,0.024756068,658.9994078,9.364133359,-5.668994932,-5.104680429,-5.336074014,1
P60660,MYL6,MYL6_HUMAN,brush border [GO:0005903]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myosin complex [GO:0016459]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin-dependent ATPase activity [GO:0030898]; calcium ion binding [GO:0005509]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle tissue development [GO:0007519],,Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3) (Smooth muscle and nonmuscle myosin light chain alkali 6),GO:0003774; GO:0005509; GO:0005829; GO:0005903; GO:0006936; GO:0007519; GO:0008307; GO:0016020; GO:0016459; GO:0016461; GO:0030049; GO:0030898; GO:0031982; GO:0070062,0.01572717,0.016879021,0.007843172,0.057142948,0.061903511,0.048818078,0.057142948,-4.129280734,0.042471724,0.034718983,9.265289601,0.000520999,0.013273075,-2.743160136,16930,1.877028457,3,0,0,0.01572717,0.057142948,3.633390247,1.861316328,-4.129280734,-4.013834948,-4.356440695,1
Q86VP1,TAX1BP1,TAXB1_HUMAN,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon production [GO:0032480]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803],,Tax1-binding protein 1 (TRAF6-binding protein),GO:0005829; GO:0006915; GO:0010803; GO:0019900; GO:0032088; GO:0032480; GO:0043066; GO:0046872; GO:0070062,5.61E-05,5.69E-05,6.46E-05,0.173340277,0.119032571,0.171219664,0.171219664,-2.546079695,0.154471668,0.077295004,9.037894842,0.000577454,0.014025638,-2.868835422,90877,1.853077365,4,0,0,5.69E-05,0.171219664,3009.887663,11.55549393,-2.528321181,-3.070571698,-2.546079695,1
Q92604,LPGAT1,LGAT1_HUMAN,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid biosynthetic process [GO:0045723],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15485873}; Multi-pass membrane protein {ECO:0000269|PubMed:15485873}.,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 (EC 2.3.1.-),GO:0003841; GO:0005737; GO:0005789; GO:0008654; GO:0016020; GO:0016021; GO:0036148; GO:0045723; GO:0047144,1.00E-07,1.00E-07,1.00E-07,0.080195184,0.061693977,0.054264376,0.061693977,-4.01872653,0.065384412,0.032692306,8.812180366,0.000641058,0.01486946,-2.996427537,43089,1.827704808,9,3,0,1.00E-07,0.061693977,616939.7742,19.23477013,-3.640340596,-4.01872653,-4.203850787,1
Q8IWZ3,ANKHD1,ANKH1_HUMAN,cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16098192, ECO:0000269|PubMed:16956752}.",Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK),GO:0003723; GO:0005737; GO:0045087,0.000277866,0.000387508,0.000266683,0.051349821,0.054655093,0.036545962,0.051349821,-4.283496935,0.047206273,0.023913822,8.809169629,0.000641962,0.01486946,-2.99814916,269458,1.827704808,12,0,0,0.000277866,0.051349821,184.8009526,7.529828383,-4.283496935,-4.193500259,-4.774144199,1
Q9H9T3,ELP3,ELP3_HUMAN,cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; histone acetyltransferase complex [GO:0000123]; nucleolus [GO:0005730]; transcription elongation factor complex [GO:0008023]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; phosphorylase kinase regulator activity [GO:0008607]; central nervous system development [GO:0007417]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19185337}.; SUBCELLULAR LOCATION: Isoform 1: Nucleus.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Nucleus.,Elongator complex protein 3 (hELP3) (EC 2.3.1.48),GO:0000123; GO:0001764; GO:0005730; GO:0005737; GO:0006357; GO:0006368; GO:0007417; GO:0008023; GO:0008607; GO:0010484; GO:0010485; GO:0030335; GO:0033588; GO:0043966; GO:0043967; GO:0046872; GO:0051536,1.00E-07,1.00E-07,1.00E-07,0.094179848,0.108344081,0.071154854,0.094179848,-3.408437796,0.091226161,0.04561318,8.747266819,0.000660913,0.015126784,-3.033664063,62259,1.820253394,8,3,0,1.00E-07,0.094179848,941798.4795,19.84505887,-3.408437796,-3.206307757,-3.812894022,1
Q96B54,ZNF428,ZN428_HUMAN,metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],,Zinc finger protein 428 (Enzyme-like protein PIT13),GO:0003676; GO:0046872,0.000261351,0.000181839,0.000536055,0.239667961,0.243536717,0.164755717,0.239667961,-2.060891031,0.215660384,0.108156607,8.739881203,0.00066322,0.015139092,-3.037916328,20481,1.819900161,3,0,0,0.000261351,0.239667961,917.0360123,9.84083458,-2.060891031,-2.037788798,-2.601599568,1
Q15061,WDR43,WDR43_HUMAN,"fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849, ECO:0000269|PubMed:24219289}. Note=Found predominantly at the fibrillar center. {ECO:0000269|PubMed:24219289}.",WD repeat-containing protein 43 (U3 small nucleolar RNA-associated protein 5 homolog),GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0006351; GO:0006364; GO:0045943; GO:2000234,1.00E-07,0.000618726,1.00E-07,0.034397201,0.025216217,0.02398105,0.025216217,-5.309504332,0.027658514,0.014035566,8.728810861,0.000666695,0.015177951,-3.044296087,74891,1.818786865,5,2,0,1.00E-07,0.025216217,252162.1705,17.94399233,-4.861565023,-5.309504332,-5.381961386,1
Q13485,SMAD4,SMAD4_HUMAN,"activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; collagen binding [GO:0005518]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; RNA polymerase II transcription factor binding [GO:0001085]; sulfate binding [GO:0043199]; transcription regulatory region DNA binding [GO:0044212]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [GO:0030616]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; protein deubiquitination [GO:0016579]; protein homotrimerization [GO:0070207]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15799969, ECO:0000269|PubMed:17327236}. Nucleus {ECO:0000269|PubMed:15799969}. Note=Cytoplasmic in the absence of ligand. Migrates to the nucleus when complexed with R-SMAD (PubMed:15799969). PDPK1 prevents its nuclear translocation in response to TGF-beta (PubMed:17327236). {ECO:0000269|PubMed:15799969, ECO:0000269|PubMed:17327236}.",Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001077; GO:0001085; GO:0001541; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007411; GO:0007492; GO:0007498; GO:0008283; GO:0008285; GO:0010614; GO:0010718; GO:0010862; GO:0014033; GO:0016579; GO:0017015; GO:0030308; GO:0030509; GO:0030511; GO:0030513; GO:0030616; GO:0032444; GO:0032525; GO:0032909; GO:0033686; GO:0035019; GO:0035556; GO:0036302; GO:0042118; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0046982; GO:0048589; GO:0048663; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0061614; GO:0062009; GO:0070102; GO:0070207; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071559; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:1901522; GO:1905305; GO:2000617,0.002728567,0.005115338,0.001348484,0.122142666,0.088551537,0.086987635,0.088551537,-3.497338834,0.09616315,0.051145705,8.674316655,0.000684131,0.015451606,-3.075806362,60439,1.811026365,6,0,0,0.002728567,0.088551537,32.45349292,5.020301857,-3.033360853,-3.497338834,-3.523045846,1
Q14318,FKBP8,FKBP8_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; FK506 binding [GO:0005528]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; chaperone-mediated protein folding [GO:0061077]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032],"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16176796}. Mitochondrion membrane {ECO:0000305}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 1: Mitochondrion membrane {ECO:0000269|PubMed:12510191, ECO:0000269|PubMed:18385096}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 3: Mitochondrion membrane {ECO:0000269|PubMed:18385096}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.",Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase),GO:0001708; GO:0001933; GO:0003755; GO:0005528; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006915; GO:0007224; GO:0016020; GO:0016032; GO:0021904; GO:0030176; GO:0030513; GO:0031966; GO:0032991; GO:0035264; GO:0035556; GO:0042802; GO:0043010; GO:0043066; GO:0046872; GO:0061077; GO:0097718,0.001032628,0.000412188,0.000380419,0.259322703,0.269549919,0.179615804,0.259322703,-1.947179579,0.235554397,0.11838561,8.609930621,0.000705454,0.015620803,-3.113264644,44562,1.806296644,9,0,0,0.000412188,0.259322703,629.1363263,9.297228855,-1.947179579,-1.891375617,-2.477013803,1
Q8WX77,IGFBPL1,IBPL1_HUMAN,extracellular space [GO:0005615]; insulin-like growth factor binding [GO:0005520]; cellular response to tumor cell [GO:0071228]; regulation of cell growth [GO:0001558],SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15845387}.,Insulin-like growth factor-binding protein-like 1 (IGFBP-related protein 10) (Insulin-like growth factor-binding-related protein 4) (IGFBP-rP4),GO:0001558; GO:0005520; GO:0005615; GO:0071228,0.031658685,0.016848208,0.021881447,0.075425324,0.063826489,0.067096681,0.067096681,-3.897614796,0.045320051,0.046122805,8.481340312,0.000750523,0.016240841,-3.188827244,29005,1.789391478,4,0,0,0.021881447,0.067096681,3.066373142,1.616533267,-3.72880721,-3.969700902,-3.897614796,1
Q29RF7,PDS5A,PDS5A_HUMAN,"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell division [GO:0051301]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of DNA replication [GO:0008156]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11076961, ECO:0000269|PubMed:15019998}. Note=Associated with chromatin through most of the cell cycle. Dissociates from chromatin in late prophase, reassociates during late telophase. {ECO:0000269|PubMed:11076961, ECO:0000269|PubMed:15019998}.",Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112) (SCC-112),GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0005886; GO:0006281; GO:0007064; GO:0008156; GO:0051301,0.013630373,0.026364807,0.046269207,0.107418238,0.108133225,0.104236868,0.107418238,-3.218689126,0.077841315,0.067675453,8.449369247,0.000762269,0.016394048,-3.207771955,150830,1.785313789,24,0,0,0.026364807,0.107418238,4.074304072,2.026553655,-3.218689126,-3.209118222,-3.262062453,1
O95155,UBE4B,UBE4B_HUMAN,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin-ubiquitin ligase activity [GO:0034450]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9ES00}. Nucleus {ECO:0000250|UniProtKB:Q9ES00}.,Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (Homozygously deleted in neuroblastoma 1) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2),GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0019899; GO:0030433; GO:0031175; GO:0034450; GO:0043161; GO:0051117; GO:0051865,1.40E-05,1.00E-07,1.00E-07,0.114371402,0.125324063,0.080891314,0.114371402,-3.128201731,0.106857528,0.053433496,8.30793524,0.000817001,0.017057377,-3.292348537,146185,1.768087752,21,2,0,1.00E-07,0.114371402,1143714.024,20.12529493,-3.128201731,-2.996264645,-3.627871392,1
Q02543,RPL18A,RL18A_HUMAN,"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]",,60S ribosomal protein L18a (Large ribosomal subunit protein eL20),GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0022625; GO:0042788; GO:0097327,0.001287376,0.005136759,0.002357908,0.032047334,0.027871925,0.022197875,0.027871925,-5.165043558,0.02444503,0.015149863,8.256014816,0.000838288,0.017374693,-3.32371592,20762,1.760082865,4,0,0,0.002357908,0.027871925,11.82061456,3.563233138,-4.963651835,-5.165043558,-5.493434625,1
P19838,NFKB1,NFKB1_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; I-kappaB/NF-kappaB complex [GO:0033256]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; actinin binding [GO:0042805]; chromatin binding [GO:0003682]; DNA binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0001205]; transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001227]; apoptotic process [GO:0006915]; cellular response to angiotensin [GO:1904385]; cellular response to dsRNA [GO:0071359]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cellular response to tumor necrosis factor [GO:0071356]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; membrane protein intracellular domain proteolysis [GO:0031293]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-12 biosynthetic process [GO:0045083]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon production [GO:0032481]; response to muscle stretch [GO:0035994]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).",Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit],GO:0000122; GO:0000976; GO:0000977; GO:0000980; GO:0000981; GO:0001205; GO:0001227; GO:0002223; GO:0003682; GO:0003700; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006366; GO:0006915; GO:0006954; GO:0007249; GO:0008134; GO:0010629; GO:0010744; GO:0010884; GO:0010956; GO:0010957; GO:0031293; GO:0032269; GO:0032375; GO:0032481; GO:0033256; GO:0034774; GO:0035580; GO:0035994; GO:0038061; GO:0038095; GO:0042802; GO:0042803; GO:0042805; GO:0043066; GO:0043312; GO:0044212; GO:0045083; GO:0045087; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0050852; GO:0051092; GO:0051403; GO:0070498; GO:0071222; GO:0071260; GO:0071316; GO:0071347; GO:0071354; GO:0071356; GO:0071359; GO:0090263; GO:1900127; GO:1904385; GO:2000630,2.13E-05,1.60E-05,3.18E-05,0.083209289,0.070180005,0.053096108,0.070180005,-3.832796145,0.068805444,0.034425745,8.199652509,0.000862168,0.017772952,-3.357964158,105356,1.750240421,4,0,0,2.13E-05,0.070180005,3298.378856,11.6875414,-3.587111593,-3.832796145,-4.235250089,1
Q9Y512,SAMM50,SAM50_HUMAN,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrial sorting and assembly machinery complex [GO:0001401]; mitochondrion [GO:0005739]; cristae formation [GO:0042407]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial outer membrane [GO:0045040],SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:15644312}; Multi-pass membrane protein. Cytoplasm {ECO:0000250|UniProtKB:Q6AXV4}. Mitochondrion {ECO:0000269|PubMed:25781180}.,Sorting and assembly machinery component 50 homolog (Transformation-related gene 3 protein) (TRG-3),GO:0001401; GO:0005739; GO:0005741; GO:0016021; GO:0033108; GO:0042407; GO:0045040; GO:0070062,6.17E-05,3.37E-05,2.20E-06,0.026009687,0.025718431,0.017142101,0.025718431,-5.281053531,0.022924227,0.011494627,8.188213969,0.000867115,0.017799779,-3.364939995,51976,1.749585402,12,0,0,3.37E-05,0.025718431,764.0757295,9.577571824,-5.264807132,-5.281053531,-5.86631226,1
Q96SB4,SRPK1,SRPK1_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm chromatin condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Nucleus. Nucleus matrix. Microsome. Note=Shuttles between the nucleus and the cytoplasm. Inhibition of the Hsp90 ATPase activity, osmotic stress and interaction with HHV-1 ICP27 protein can induce its translocation to the nucleus. KAT5/TIP60 inhibits its nuclear translocation.; SUBCELLULAR LOCATION: Isoform 1: Cytoplasm. Nucleus matrix. Microsome. Note=Mainly localized in the microsomal fraction and the cytoplasm, and to a lesser extent in the nuclear matrix.",SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1),GO:0000245; GO:0000287; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016032; GO:0016363; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684,0.027060392,0.00021092,0.0003275,0.118010127,0.116018729,0.154305054,0.118010127,-3.083017427,0.120245033,0.06932212,8.157593364,0.00088053,0.017932307,-3.383656327,74325,1.746363831,10,0,0,0.0003275,0.118010127,360.3365487,8.493201181,-3.083017427,-3.107570379,-2.696142777,1
Q8WYK1,CNTNAP5,CNTP5_HUMAN,integral component of membrane [GO:0016021]; cell adhesion [GO:0007155],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,Contactin-associated protein-like 5 (Cell recognition molecule Caspr5),GO:0007155; GO:0016021,6.97E-05,0.000110789,5.18E-05,0.211458027,0.224389853,0.144813987,0.211458027,-2.241556771,0.19347652,0.096815696,8.154382985,0.000881951,0.017932307,-3.38562219,145623,1.746363831,17,0,0,6.97E-05,0.211458027,3033.097046,11.56657594,-2.241556771,-2.155920656,-2.787727147,1
Q86XX4,FRAS1,FRAS1_HUMAN,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sublamina densa [GO:0061618]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588],SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}; Extracellular side {ECO:0000305}.,Extracellular matrix protein FRAS1,GO:0002009; GO:0003338; GO:0005886; GO:0007154; GO:0015031; GO:0016021; GO:0030326; GO:0043588; GO:0046872; GO:0060021; GO:0061618,8.24E-05,0.005024854,9.48E-05,0.170672784,0.195343544,0.124970522,0.170672784,-2.550695077,0.16192826,0.082698153,8.136017823,0.000890134,0.018055804,-3.396881106,443214,1.743383173,5,0,0,9.48E-05,0.170672784,1800.963812,10.81455348,-2.550695077,-2.355914519,-3.000340262,1
Q5T5Y3,CAMSAP1,CAMP1_HUMAN,cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:19508979}. Note=Associates with the minus-end of microtubules (PubMed:24486153, PubMed:24706919). In contrast to CAMSAP2 and CAMSAP3, does not form stretches of decorated microtubule minus-ends (PubMed:24486153, PubMed:24706919). {ECO:0000269|PubMed:19508979, ECO:0000269|PubMed:24486153, ECO:0000269|PubMed:24706919}.",Calmodulin-regulated spectrin-associated protein 1,GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031175; GO:0051011,1.68E-05,8.85E-07,0.000195166,0.088902109,0.097037785,0.061947064,0.088902109,-3.49163854,0.082558049,0.041349962,8.089463087,0.000911297,0.018270938,-3.425522097,177972,1.738239164,30,0,0,1.68E-05,0.088902109,5304.104092,12.37289337,-3.49163854,-3.365309565,-4.01282029,1
Q96FJ0,STAMBPL1,STALP_HUMAN,cytosol [GO:0005829]; membrane [GO:0016020]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; protein deubiquitination [GO:0016579],,AMSH-like protease (AMSH-LP) (EC 3.4.19.-) (STAM-binding protein-like 1),GO:0005829; GO:0008237; GO:0016020; GO:0016579; GO:0046872; GO:0061578,1.00E-07,1.00E-07,1.00E-07,0.125525112,0.11467907,0.08001948,0.11467907,-3.12432598,0.106741121,0.05337066,8.08240428,0.000914559,0.018270938,-3.429877363,49783,1.738239164,5,3,0,1.00E-07,0.11467907,1146790.704,20.12917068,-2.993952088,-3.12432598,-3.643504939,1
Q9GZY8,MFF,MFF_HUMAN,cell junction [GO:0030054]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle [GO:0008021]; protein homodimerization activity [GO:0042803]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; peroxisome fission [GO:0016559]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein homooligomerization [GO:0051260]; protein targeting to mitochondrion [GO:0006626]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; release of cytochrome c from mitochondria [GO:0001836],"SUBCELLULAR LOCATION: Mitochondrion outer membrane; Single-pass type IV membrane protein. Peroxisome. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle {ECO:0000250}.",Mitochondrial fission factor,GO:0000266; GO:0001836; GO:0005739; GO:0005741; GO:0005777; GO:0006626; GO:0008021; GO:0008053; GO:0010821; GO:0016559; GO:0030054; GO:0032592; GO:0042803; GO:0043653; GO:0051260; GO:0070584; GO:0090141; GO:0090200; GO:0090314; GO:1900063,7.73E-06,1.78E-05,3.27E-05,0.089439381,0.071610741,0.057115988,0.071610741,-3.803680201,0.072702632,0.036370721,8.081709102,0.000914881,0.018270938,-3.430306466,38465,1.738239164,7,0,0,1.78E-05,0.071610741,4025.221058,11.9748523,-3.482945987,-3.803680201,-4.129961544,1
Q9Y2Q5,LAMTOR2,LTOR2_HUMAN,endosome membrane [GO:0010008]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex scaffold activity [GO:0032947]; activation of MAPKK activity [GO:0000186]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]; regulation of macroautophagy [GO:0016241],SUBCELLULAR LOCATION: Late endosome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Lysosome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}.,Ragulator complex protein LAMTOR2 (Endosomal adaptor protein p14) (Late endosomal/lysosomal Mp1-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2) (Mitogen-activated protein-binding protein-interacting protein) (MAPBP-interacting protein) (Roadblock domain-containing protein 3),GO:0000165; GO:0000186; GO:0001558; GO:0005085; GO:0005765; GO:0005770; GO:0005886; GO:0007050; GO:0010008; GO:0016241; GO:0032008; GO:0032947; GO:0034613; GO:0035579; GO:0043312; GO:0070821; GO:0071230; GO:0071986,0.005655256,0.000748101,0.001460773,0.047617388,0.049233863,0.033370511,0.047617388,-4.392367709,0.040785877,0.023014315,8.045393082,0.000931897,0.018441119,-3.452767849,13508,1.734212721,3,0,0,0.001460773,0.047617388,32.59739116,5.026684602,-4.392367709,-4.344205253,-4.905282407,1
P09651,HNRNPA1,ROA1_HUMAN,"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; telomeric repeat-containing RNA binding [GO:0061752]; cellular response to glucose starvation [GO:0042149]; cellular response to sodium arsenite [GO:1903936]; fibroblast growth factor receptor signaling pathway [GO:0008543]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear export [GO:0051168]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]; RNA metabolic process [GO:0016070]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:27694260}. Cytoplasm {ECO:0000269|PubMed:17289661}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Shuttles continuously between the nucleus and the cytoplasm along with mRNA. Component of ribonucleosomes (PubMed:17289661). {ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:27694260}.; SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17229681}. Note=(Microbial infection) In the course of viral infection, colocalizes with HCV NS5B at speckles in the cytoplasm in a HCV-replication dependent manner. {ECO:0000269|PubMed:17229681}.","Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]",GO:0000381; GO:0000398; GO:0003697; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006405; GO:0008543; GO:0016020; GO:0016032; GO:0016070; GO:0019904; GO:0032211; GO:0032212; GO:0035198; GO:0036002; GO:0042149; GO:0042802; GO:0051028; GO:0051168; GO:0051170; GO:0061752; GO:0070062; GO:0071013; GO:0098505; GO:1903936; GO:1990904,1.00E-07,1.00E-07,1.00E-07,0.005262503,0.007123508,0.008374353,0.007123508,-7.133196479,0.006920021,0.003460111,7.938681663,0.000984179,0.019146753,-3.519285425,38747,1.717904854,5,3,0,1.00E-07,0.007123508,71235.07649,16.12030019,-7.570035186,-7.133196479,-6.899806602,1
Q9ULB1,NRXN1,NRX1A_HUMAN,"cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; prepulse inhibition [GO:0060134]; regulation of grooming behavior [GO:2000821]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}. Cell junction, synapse {ECO:0000305}. Note=Localized on the pre-synaptic membrane. {ECO:0000250}.",Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha),GO:0005246; GO:0005509; GO:0005730; GO:0005783; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007269; GO:0007411; GO:0007416; GO:0007612; GO:0009986; GO:0030054; GO:0030534; GO:0031965; GO:0031982; GO:0032991; GO:0033130; GO:0035176; GO:0038023; GO:0042297; GO:0042734; GO:0043025; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0060134; GO:0061178; GO:0071625; GO:0090129; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:0099560; GO:2000463; GO:2000821,0.000109436,0.016810316,0.000120973,0.106541013,0.089683028,0.073462751,0.089683028,-3.479021204,0.084215355,0.04778792,7.917239523,0.000995112,0.019315545,-3.532745255,161883,1.714093043,14,0,0,0.000120973,0.089683028,741.348865,9.534008798,-3.230519195,-3.479021204,-3.766843262,1
Q12926,ELAVL2,ELAV2_HUMAN,"nucleoplasm [GO:0005654]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of transcription, DNA-templated [GO:0006355]",,ELAV-like protein 2 (ELAV-like neuronal protein 1) (Hu-antigen B) (HuB) (Nervous system-specific RNA-binding protein Hel-N1),GO:0000398; GO:0003723; GO:0003730; GO:0005654; GO:0006355,1.00E-07,1.00E-07,1.00E-07,0.118762703,0.162748301,0.106208975,0.118762703,-3.073846266,0.129239893,0.064620046,7.834272239,0.001038833,0.019673472,-3.585126907,39504,1.706118978,5,3,0,1.00E-07,0.118762703,1187627.026,20.1796504,-3.073846266,-2.619285611,-3.235022409,1
Q5SQI0,ATAT1,ATAT_HUMAN,"axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule bundle [GO:0097427]; mitotic spindle [GO:0072686]; coenzyme binding [GO:0050662]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; cilium assembly [GO:0060271]; dentate gyrus development [GO:0021542]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; spermatogenesis [GO:0007283]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:24097348}. Membrane, clathrin-coated pit {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:24097348}. Cell junction, focal adhesion {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:24097348}. Cell projection, axon {ECO:0000255|HAMAP-Rule:MF_03130}. Cytoplasm, cytoskeleton {ECO:0000255|HAMAP-Rule:MF_03130}. Cytoplasm, cytoskeleton, spindle {ECO:0000255|HAMAP-Rule:MF_03130}.",Alpha-tubulin N-acetyltransferase 1 (Alpha-TAT) (Alpha-TAT1) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog),GO:0004468; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0005925; GO:0007283; GO:0019799; GO:0021542; GO:0030424; GO:0045598; GO:0050662; GO:0060271; GO:0070507; GO:0071929; GO:0072686; GO:0097427; GO:1900227,0.00046561,1.00E-07,1.00E-07,0.017780397,0.01708521,0.0112225,0.01708521,-5.87110823,0.015207433,0.007758986,7.574064214,0.001191993,0.021755782,-3.752588166,46810,1.6624253,15,2,0,1.00E-07,0.01708521,170852.0976,17.38238843,-5.813568631,-5.87110823,-6.47746206,1
Q7Z5N4,SDK1,SDK1_HUMAN,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; behavioral response to cocaine [GO:0048148]; cell-cell junction organization [GO:0045216]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q8AV58}; Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q8AV58}. Cell junction, synapse {ECO:0000250|UniProtKB:Q8AV58}.",Protein sidekick-1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0030054; GO:0042802; GO:0045202; GO:0045216; GO:0048148; GO:0060998,3.97E-05,4.36E-05,4.38E-05,0.078364573,0.127350822,0.102337643,0.102337643,-3.28859119,0.102641972,0.051363359,7.541562255,0.001213002,0.021960323,-3.773852691,242112,1.658361276,8,0,0,4.36E-05,0.102337643,2349.044286,11.1978582,-3.673654606,-2.973119828,-3.28859119,1
Q9BTC8,MTA3,MTA3_HUMAN,"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; protein-containing complex binding [GO:0044877]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00512, ECO:0000255|PROSITE-ProRule:PRU00624, ECO:0000269|PubMed:12705869}.",Metastasis-associated protein MTA3,GO:0000981; GO:0003682; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008284; GO:0010971; GO:0043231; GO:0043565; GO:0044877; GO:0045892,0.004885753,0.015633444,0.002540867,0.085180486,0.081341738,0.058413134,0.081341738,-3.619860368,0.067291765,0.04133257,7.536469996,0.001216334,0.021960323,-3.777191452,67504,1.658361276,3,0,0,0.004885753,0.081341738,16.64876281,4.057343068,-3.553333225,-3.619860368,-4.097563399,1
P06576,ATP5F1B,ATPB_HUMAN,"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transmembrane transporter activity [GO:0022857]; transporter activity [GO:0005215]; angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; cristae formation [GO:0042407]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrion organization [GO:0007005]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]",SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250|UniProtKB:P00829}; Peripheral membrane protein {ECO:0000250|UniProtKB:P00829}; Matrix side {ECO:0000250|UniProtKB:P00829}.,"ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) (ATP synthase F1 subunit beta)",GO:0001525; GO:0001649; GO:0005215; GO:0005524; GO:0005634; GO:0005739; GO:0005753; GO:0005754; GO:0005759; GO:0005886; GO:0006091; GO:0006629; GO:0006754; GO:0006933; GO:0007005; GO:0009986; GO:0016020; GO:0022857; GO:0031966; GO:0042288; GO:0042407; GO:0042645; GO:0042776; GO:0043209; GO:0043532; GO:0043536; GO:0045259; GO:0046933; GO:0046961; GO:0051453; GO:0070062; GO:1902600,1.00E-07,1.00E-07,1.00E-07,0.024340123,0.024609061,0.015554733,0.024340123,-5.360519746,0.021501206,0.010750703,7.510311231,0.001233628,0.022070122,-3.794373149,56560,1.656195265,21,3,0,1.00E-07,0.024340123,243401.2275,17.89297692,-5.360519746,-5.344666577,-6.006502535,1
O43913,ORC5,ORC5_HUMAN,"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]",SUBCELLULAR LOCATION: Nucleus.,Origin recognition complex subunit 5,GO:0000082; GO:0000166; GO:0000784; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270,0.000257429,0.036445425,0.000390507,0.126625144,0.175881615,0.142160265,0.142160265,-2.81440982,0.135857888,0.080293398,7.478307945,0.001255195,0.022070122,-3.815463623,50283,1.656195265,3,0,0,0.000390507,0.142160265,364.040539,8.507955306,-2.981364183,-2.507323409,-2.81440982,1
Q9UI36,DACH1,DACH1_HUMAN,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly [GO:0001075]; transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001078]; cell proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; multicellular organism development [GO:0007275]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; respiratory gaseous exchange [GO:0007585]; suckling behavior [GO:0001967]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14525983}.,Dachshund homolog 1 (Dach1),GO:0001075; GO:0001078; GO:0001967; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0007275; GO:0007585; GO:0008283; GO:0010944; GO:0030336; GO:0033262; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279,0.000317389,0.000670601,0.002701842,0.218253968,0.199943808,0.134455894,0.199943808,-2.322333491,0.182987946,0.092723917,7.472039257,0.001259473,0.022070122,-3.819603806,78676,1.656195265,8,0,0,0.000670601,0.199943808,298.1560406,8.219923756,-2.19592021,-2.322333491,-2.894795093,1
Q8ND83,SLAIN1,SLAI1_HUMAN,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:21646404}. Note=Colocalizes with microtubules. Detected at the plus end of growing microtubules. {ECO:0000269|PubMed:21646404}.",SLAIN motif-containing protein 1,GO:0005737; GO:0005856,0.029262586,0.053977048,0.037606013,0.134712698,0.140901997,0.108577527,0.134712698,-2.892042252,0.087782192,0.084172978,7.427400555,0.001290455,0.022451818,-3.849171912,60595,1.648748484,6,0,0,0.037606013,0.134712698,3.582211626,1.84085057,-2.892042252,-2.827236033,-3.203202564,1
Q8N2K0,ABHD12,ABD12_HUMAN,AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; protein depalmitoylation [GO:0002084]; response to auditory stimulus [GO:0010996],SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q99LR1}; Single-pass membrane protein {ECO:0000250|UniProtKB:Q99LR1}.,Monoacylglycerol lipase ABHD12 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 12),GO:0002084; GO:0004622; GO:0005886; GO:0006660; GO:0007628; GO:0008474; GO:0010996; GO:0016021; GO:0032281; GO:0032839; GO:0046464; GO:0046475; GO:0047372; GO:0052651,9.09E-05,0.000126123,0.000103653,0.045246162,0.049942538,0.030488254,0.045246162,-4.466060759,0.04178544,0.020999598,7.407810786,0.001304344,0.02250891,-3.862195928,45097,1.647645537,6,0,0,0.000103653,0.045246162,436.513866,8.769883672,-4.466060759,-4.323587042,-5.03560264,1
Q15262,PTPRK,PTPRK_HUMAN,"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]","SUBCELLULAR LOCATION: Cell junction, adherens junction. Cell membrane; Single-pass type I membrane protein.",Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48),GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041,4.39E-05,3.77E-05,4.47E-05,0.267372305,0.178892882,0.180095679,0.180095679,-2.473164525,0.208744875,0.104414518,7.40425532,0.001306884,0.02250891,-3.864562891,162102,1.647645537,5,0,0,4.39E-05,0.180095679,4103.367489,12.00259265,-1.903078058,-2.482832112,-2.473164525,1
O60231,DHX16,DHX16_HUMAN,"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20423332, ECO:0000269|PubMed:20841358, ECO:0000269|PubMed:25296192}. Nucleus, nucleoplasm {ECO:0000269|PubMed:20423332}.",Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),GO:0000398; GO:0003723; GO:0003724; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0008380; GO:0016887,4.29E-05,2.22E-05,0.00098944,0.106292351,0.091638812,0.064436383,0.091638812,-3.447897427,0.087104334,0.043903682,7.378478826,0.001325482,0.022783378,-3.881752023,119264,1.642381875,14,0,0,4.29E-05,0.091638812,2135.445072,11.06032107,-3.233890307,-3.447897427,-3.955980674,1
Q9UHG3,PCYOX1,PCYOX_HUMAN,extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; very-low-density lipoprotein particle [GO:0034361]; chloride-transporting ATPase activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]; prenylcysteine metabolic process [GO:0030329],SUBCELLULAR LOCATION: Lysosome.,Prenylcysteine oxidase 1 (EC 1.8.3.5) (Prenylcysteine lyase),GO:0001735; GO:0005764; GO:0005774; GO:0005886; GO:0008555; GO:0030327; GO:0030328; GO:0030329; GO:0034361; GO:0070062,1.33E-05,8.40E-06,0.000283085,0.01637816,0.026665697,0.020600262,0.020600262,-5.601193535,0.021113106,0.010658153,7.343442526,0.001351279,0.022847407,-3.9051984,56640,1.641163082,22,0,0,1.33E-05,0.020600262,1547.122722,10.59537192,-5.932082932,-5.22887115,-5.601193535,1
Q96S59,RANBP9,RANB9_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; Ran GTPase binding [GO:0008536]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; axon guidance [GO:0007411]; MAPK cascade [GO:0000165]; microtubule nucleation [GO:0007020]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; protein-containing complex assembly [GO:0065003],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14511641, ECO:0000269|PubMed:15381419, ECO:0000269|PubMed:15558019, ECO:0000269|PubMed:18222118}. Nucleus {ECO:0000269|PubMed:14511641, ECO:0000269|PubMed:15381419, ECO:0000269|PubMed:15558019, ECO:0000269|PubMed:18222118}. Cell membrane; Peripheral membrane protein {ECO:0000269|PubMed:14722085}. Note=The unphosphorylated form is predominantly cytoplasmic. A phosphorylated form is associated with the plasma membrane. {ECO:0000269|PubMed:14722085}.",Ran-binding protein 9 (RanBP9) (BPM-L) (BPM90) (Ran-binding protein M) (RanBPM) (RanBP7),GO:0000165; GO:0005088; GO:0005634; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0007020; GO:0007411; GO:0008536; GO:0019899; GO:0065003; GO:0070373,0.004592956,0.009212171,0.01533865,0.200282205,0.252535071,0.158049941,0.200282205,-2.319893852,0.193907813,0.106668499,7.325992469,0.001364355,0.022975393,-3.916911596,77847,1.638737045,6,0,0,0.009212171,0.200282205,21.74104261,4.442349223,-2.319893852,-1.985444337,-2.661547594,1
Q9UI30,TRMT112,TR112_HUMAN,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488],"SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:25851604}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:25851604}. Note=Localizes to a polarized perinuclear structure, overlapping partially with the Golgi and lysosomes (PubMed:25851604). {ECO:0000269|PubMed:25851604}.",Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog),GO:0005654; GO:0005829; GO:0008276; GO:0018364; GO:0030488; GO:0032991; GO:0046982; GO:0048471; GO:0070476; GO:2000234,1.00E-07,1.00E-07,1.00E-07,0.078699134,0.081621773,0.050374112,0.078699134,-3.667508424,0.070231573,0.035115887,7.32357751,0.001366177,0.022975393,-3.918534486,14199,1.638737045,6,3,0,1.00E-07,0.078699134,786991.3427,19.58598824,-3.667508424,-3.614902136,-4.311173686,1
Q9BRS2,RIOK1,RIOK1_HUMAN,"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:21081503}.",Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.3.-) (RIO kinase 1),GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0016787; GO:0030490; GO:0030688; GO:0034708; GO:0042274; GO:0046872; GO:2000234,0.043631596,0.087193414,0.099998574,0.233227246,0.22445009,0.197733642,0.22445009,-2.155533423,0.141529131,0.14770576,7.307841881,0.00137812,0.0231136,-3.929120241,65583,1.636132401,6,0,0,0.087193414,0.22445009,2.574163336,1.364103599,-2.100191759,-2.155533423,-2.338369748,1
P00387,CYB5R3,NB5R3_HUMAN,"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; blood circulation [GO:0008015]; cholesterol biosynthetic process [GO:0006695]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]",SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane; Lipid-anchor; Cytoplasmic side. Mitochondrion outer membrane; Lipid-anchor; Cytoplasmic side.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Note=Produces the soluble form found in erythrocytes.,NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form],GO:0004128; GO:0005576; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005811; GO:0005833; GO:0006695; GO:0008015; GO:0016020; GO:0016208; GO:0016491; GO:0019852; GO:0035578; GO:0043312; GO:0043531; GO:0050660; GO:0051287; GO:0071949,1.00E-07,0.004977296,1.00E-07,0.04957375,0.052934971,0.033443853,0.04957375,-4.334279786,0.043658359,0.023488345,7.269558434,0.001407711,0.023277717,-3.954955634,34235,1.633059621,8,2,0,1.00E-07,0.04957375,495737.503,18.91921688,-4.334279786,-4.239635055,-4.902115142,1
Q76I76,SSH2,SSH2_HUMAN,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; protein dephosphorylation [GO:0006470]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of lamellipodium assembly [GO:0010591],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.",Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L),GO:0003779; GO:0004721; GO:0004725; GO:0005615; GO:0005737; GO:0005856; GO:0006470; GO:0008064; GO:0008138; GO:0010591; GO:0030036; GO:0050770,0.016632369,0.033209123,0.041101076,0.125329084,0.163552575,0.121476223,0.125329084,-2.996206853,0.106471771,0.083550075,7.258169541,0.001416663,0.023365386,-3.962663672,158216,1.631427035,9,0,0,0.033209123,0.125329084,3.773935381,1.916069721,-2.996206853,-2.612173619,-3.041254139,1
O75489,NDUFS3,NDUS3_HUMAN,"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762]",SUBCELLULAR LOCATION: Mitochondrion inner membrane.,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)",GO:0003954; GO:0005739; GO:0005747; GO:0005759; GO:0006120; GO:0008137; GO:0009055; GO:0016604; GO:0021762; GO:0030308; GO:0031966; GO:0032981; GO:0043209; GO:0045333; GO:0072593; GO:2001243,1.00E-07,1.00E-07,1.00E-07,0.019485782,0.030438267,0.021051784,0.021051784,-5.569913662,0.023658511,0.011829356,7.187537857,0.001473753,0.024056784,-4.010697717,30242,1.618762436,11,3,0,1.00E-07,0.021051784,210517.8444,17.683583,-5.681434333,-5.037969957,-5.569913662,1
P17980,PSMC3,PRS6A_HUMAN,"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; blastocyst development [GO:0001824]; modulation by host of viral transcription [GO:0043921]; neutrophil degranulation [GO:0043312]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Nucleus {ECO:0000305}. Note=Colocalizes with TRIM5 in the cytoplasmic bodies. {ECO:0000250|UniProtKB:O88685}.,26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1),GO:0000502; GO:0000932; GO:0001824; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0016020; GO:0016032; GO:0016579; GO:0016887; GO:0017025; GO:0022624; GO:0030433; GO:0031595; GO:0031597; GO:0034774; GO:0036402; GO:0042802; GO:0043312; GO:0043687; GO:0043921; GO:0045899; GO:0045944; GO:1904813,0.001400359,0.001490376,0.000719115,0.006254083,0.005015311,0.007413797,0.006254083,-7.320985891,0.005024447,0.003715507,7.091949321,0.001555538,0.024703906,-4.076343547,49204,1.607234373,21,0,0,0.001400359,0.006254083,4.466056503,2.159001504,-7.320985891,-7.639445147,-7.075571592,1
Q9NSI2,FAM207A,F207A_HUMAN,,,Protein FAM207A,,2.60E-05,1.00E-07,0.005891786,0.254111049,0.234341587,0.152776094,0.234341587,-2.093315094,0.211770273,0.107857774,7.081265714,0.001565018,0.024808429,-4.083726829,25456,1.605400734,3,1,0,2.60E-05,0.234341587,9004.410627,13.13641613,-1.97646899,-2.093315094,-2.71050928,1
Q9BQ95,ECSIT,ECSIT_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; regulation of oxidoreductase activity [GO:0051341]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17344420}. Nucleus {ECO:0000269|PubMed:17344420}. Mitochondrion {ECO:0000269|PubMed:17344420}.,"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial (Protein SITPEC)",GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005829; GO:0016651; GO:0032981; GO:0045087; GO:0051341,1.00E-07,1.00E-07,2.57E-06,0.047591003,0.028310185,0.03747997,0.03747997,-4.737736397,0.037792796,0.018897321,7.052383734,0.001590999,0.024961443,-4.103733747,49148,1.602730317,6,2,0,1.00E-07,0.03747997,374799.6986,18.51576027,-4.39316734,-5.142535037,-4.737736397,1
O75688,PPM1B,PPM1B_HUMAN,cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:22781750}. Membrane {ECO:0000250|UniProtKB:P36993}; Lipid-anchor {ECO:0000250|UniProtKB:P36993}. Note=Weakly associates at the membrane and N-myristoylation mediates the membrane localization. {ECO:0000250|UniProtKB:P36993}.",Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta),GO:0000287; GO:0004722; GO:0005730; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:1901223,9.93E-05,0.000201127,0.000137694,0.041967316,0.042883761,0.02615235,0.041967316,-4.574589977,0.036855093,0.018573596,7.051098773,0.001592167,0.024961443,-4.104625455,52643,1.602730317,9,0,0,0.000137694,0.041967316,304.7863409,8.251654439,-4.574589977,-4.543424763,-5.256915597,1
O60216,RAD21,RAD21_HUMAN,"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear cohesin complex [GO:0000798]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; protein-containing complex binding [GO:0044877]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]; apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; reciprocal meiotic recombination [GO:0007131]; regulation of transcription by RNA polymerase II [GO:0006357]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10623634}. Chromosome {ECO:0000269|PubMed:11073952}. Chromosome, centromere {ECO:0000269|PubMed:11073952}. Note=Associates with chromatin. Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK, except at centromeres, where cohesin complexes remain. At anaphase, it is cleaved by separase/ESPL1, leading to the dissociation of the complex from chromosomes, allowing chromosome separation. Once cleaved by caspase-3, the C-terminal 64 kDa cleavage product translocates to the cytoplasm, where it may trigger apoptosis. {ECO:0000269|PubMed:11073952}.",Double-strand-break repair protein rad21 homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) (SCC1 homolog),GO:0000775; GO:0000785; GO:0000798; GO:0001228; GO:0003682; GO:0005654; GO:0005694; GO:0005829; GO:0006302; GO:0006310; GO:0006357; GO:0006915; GO:0007059; GO:0007131; GO:0008278; GO:0010972; GO:0016020; GO:0016363; GO:0044877; GO:0045841; GO:0045876; GO:0051301; GO:0071168,0.000118562,0.00015166,0.000215128,0.061937288,0.041422719,0.069965079,0.061937288,-4.013047973,0.057613245,0.028968406,7.044300615,0.001598364,0.024977314,-4.109345361,71690,1.602454269,11,0,0,0.00015166,0.061937288,408.3946983,8.673820327,-4.013047973,-4.593433925,-3.837221168,1
Q13526,PIN1,PIN1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; motor activity [GO:0003774]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; cell cycle [GO:0007049]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of type I interferon production [GO:0032480]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization to nucleus [GO:1900180]; regulation of signal transduction by p53 class mediator [GO:1901796]; synapse organization [GO:0050808],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16476580, ECO:0000269|PubMed:23623683}. Nucleus speckle {ECO:0000269|PubMed:21497122}. Cytoplasm {ECO:0000269|PubMed:21497122}. Note=Colocalizes with NEK6 in the nucleus (PubMed:16476580). Mainly localized in the nucleus but phosphorylation at Ser-71 by DAPK1 results in inhibition of its nuclear localization (PubMed:21497122). {ECO:0000269|PubMed:16476580}.",Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1),GO:0000413; GO:0001934; GO:0003755; GO:0003774; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0007049; GO:0007088; GO:0008013; GO:0016607; GO:0030182; GO:0030496; GO:0030512; GO:0031434; GO:0032091; GO:0032465; GO:0032480; GO:0032794; GO:0035307; GO:0042177; GO:0043005; GO:0043524; GO:0043525; GO:0043547; GO:0045944; GO:0050808; GO:0050815; GO:0050816; GO:0050821; GO:0051219; GO:0051443; GO:0060393; GO:0061051; GO:0070373; GO:0090263; GO:1900180; GO:1901796; GO:2000146,1.00E-07,1.00E-07,1.00E-07,0.06323402,0.056710257,0.037341575,0.056710257,-4.140246505,0.052428517,0.026214359,7.006633284,0.001633235,0.025144776,-4.135566991,18243,1.599552235,3,3,0,1.00E-07,0.056710257,567102.5663,19.11325016,-3.983155245,-4.140246505,-4.743073403,1
Q15386,UBE3C,UBE3C_HUMAN,cytoplasm [GO:0005737]; intracellular [GO:0005622]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (HectH2),GO:0000209; GO:0000502; GO:0004842; GO:0005622; GO:0005634; GO:0005737; GO:0061630,1.00E-07,1.00E-07,1.00E-07,0.044732162,0.055848883,0.032725046,0.044732162,-4.482543696,0.044435264,0.022217732,6.91499671,0.001722007,0.026063521,-4.19985511,123923,1.583966907,14,3,0,1.00E-07,0.044732162,447321.6216,18.77095297,-4.482543696,-4.162327757,-4.933460983,1
Q86WA8,LONP2,LONP2_HUMAN,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; peroxisome organization [GO:0007031]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070],"SUBCELLULAR LOCATION: Peroxisome matrix {ECO:0000255|HAMAP-Rule:MF_03121, ECO:0000269|PubMed:14561759, ECO:0000269|PubMed:18281296, ECO:0000269|PubMed:22002062}.","Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease) (pLon)",GO:0002020; GO:0004176; GO:0004252; GO:0005102; GO:0005524; GO:0005634; GO:0005777; GO:0005782; GO:0005829; GO:0006515; GO:0006625; GO:0007031; GO:0008233; GO:0014070; GO:0016020; GO:0016485; GO:0019899; GO:0031998,1.00E-07,1.00E-07,1.00E-07,0.104357871,0.144970814,0.088123744,0.104357871,-3.260388682,0.112484043,0.056242122,6.913645668,0.001723359,0.026063521,-4.200808254,94617,1.583966907,11,3,0,1.00E-07,0.104357871,1043578.707,19.99310798,-3.260388682,-2.78616561,-3.504325395,1
Q59EK9,RUNDC3A,RUN3A_HUMAN,cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; guanylate cyclase activator activity [GO:0030250]; peptide hormone receptor binding [GO:0051428]; small GTPase mediated signal transduction [GO:0007264],,RUN domain-containing protein 3A (Rap2-interacting protein 8) (RPIP-8),GO:0005829; GO:0005886; GO:0007264; GO:0030250; GO:0030695; GO:0051428,1.00E-07,1.11E-05,5.96E-06,0.091250164,0.122834563,0.07345247,0.091250164,-3.454029043,0.095840024,0.04792572,6.896853084,0.001740272,0.026226637,-4.212668201,49747,1.581257393,6,1,0,5.96E-06,0.091250164,15319.59708,13.90309073,-3.454029043,-3.025211537,-3.767045194,1
Q92530,PSMF1,PSMF1_HUMAN,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; proteasome core complex [GO:0005839]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; negative regulation of proteasomal protein catabolic process [GO:1901799]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18495667}. Endoplasmic reticulum {ECO:0000269|PubMed:18495667}.,Proteasome inhibitor PI31 subunit (hPI31),GO:0004866; GO:0005654; GO:0005783; GO:0005829; GO:0005839; GO:0006511; GO:0016020; GO:0016579; GO:0042803; GO:0043687; GO:0046982; GO:0048471; GO:0070628; GO:1901799,1.52E-05,1.00E-07,2.01E-05,0.088903287,0.113450974,0.066648643,0.088903287,-3.49161943,0.089655818,0.044839726,6.892552741,0.001744636,0.02624619,-4.215709238,29817,1.580933727,5,1,0,1.52E-05,0.088903287,5845.515069,12.51311444,-3.49161943,-3.139859099,-3.907280686,1
Q96S38,RPS6KC1,KS6C1_HUMAN,early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12077123, ECO:0000269|PubMed:15750338}. Membrane {ECO:0000269|PubMed:12077123}. Early endosome {ECO:0000269|PubMed:15750338}.",Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein),GO:0004674; GO:0005524; GO:0005769; GO:0007165; GO:0016020; GO:0035091,7.49E-05,2.99E-05,4.16E-05,0.070162999,0.04763309,0.044002682,0.04763309,-4.391892061,0.053884138,0.026990854,6.842643154,0.001796264,0.026648221,-4.251119449,118682,1.574331785,14,0,0,4.16E-05,0.04763309,1144.913644,10.16102307,-3.833145771,-4.391892061,-4.506264744,1
Q9HAR2,ADGRL3,AGRL3_HUMAN,axon [GO:0030424]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G-protein coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26235030}; Multi-pass membrane protein {ECO:0000305}. Cell projection, axon {ECO:0000250|UniProtKB:Q80TS3}. Cell junction {ECO:0000250|UniProtKB:Q80TS3}.",Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007416; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742,1.00E-07,1.00E-07,0.000251697,0.13790405,0.160960504,0.092602899,0.13790405,-2.858263265,0.130405186,0.065286558,6.748639922,0.001898638,0.027499733,-4.3184001,161812,1.560671521,20,2,0,1.00E-07,0.13790405,1379040.503,20.3952334,-2.858263265,-2.635221367,-3.432798827,1
Q9UHV9,PFDN2,PFD2_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17936702}. Cytoplasm {ECO:0000269|PubMed:17936702}. Mitochondrion {ECO:0000269|PubMed:17936702}.,Prefoldin subunit 2,GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0051082; GO:0051495,1.00E-07,1.00E-07,1.00E-07,0.031125424,0.032423724,0.018857507,0.031125424,-5.005762723,0.027468785,0.013734492,6.603551611,0.002070925,0.028965873,-4.423779143,16648,1.538113382,4,3,0,1.00E-07,0.031125424,311254.2351,18.24773394,-5.005762723,-4.946806392,-5.728717264,1
Q5GH76,XKR4,XKR4_HUMAN,integral component of membrane [GO:0016021],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,XK-related protein 4,GO:0016021,0.00034926,6.70E-05,0.000100023,0.067284421,0.070097278,0.040657188,0.067284421,-3.893583689,0.05917421,0.029759191,6.554945023,0.002132846,0.029352346,-4.459507948,71501,1.532357187,3,0,0,0.000100023,0.067284421,672.6921468,9.393802606,-3.893583689,-3.834497764,-4.62034575,1
Q53EL6,PDCD4,PDCD4_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell aging [GO:0007569]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q61823}. Cytoplasm {ECO:0000250|UniProtKB:Q61823}. Note=Shuttles between the nucleus and cytoplasm (By similarity). Predominantly nuclear under normal growth conditions, and when phosphorylated at Ser-457 (PubMed:16357133). {ECO:0000269|PubMed:16357133}.",Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a),GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007569; GO:0030509; GO:0035722; GO:0043066; GO:0043508; GO:0045786; GO:0045892; GO:0050729; GO:0060940; GO:0071222; GO:1900016; GO:1901224; GO:1904706; GO:1904761; GO:1905064; GO:1905461; GO:2000353,7.00E-07,1.52E-05,1.00E-07,0.142468862,0.181127694,0.1029121,0.142468862,-2.811281457,0.142164229,0.071087437,6.542332799,0.002149278,0.029483686,-4.468814104,51735,1.530418218,6,1,0,7.00E-07,0.142468862,203645.4541,17.63570008,-2.811281457,-2.464920951,-3.280515476,1
P62879,GNB2,GBB2_HUMAN,cell body [GO:0044297]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; calcium channel regulator activity [GO:0005246]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; G-protein coupled receptor signaling pathway [GO:0007186]; protein folding [GO:0006457],"SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:16498633}.",Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2),GO:0003924; GO:0005246; GO:0005615; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0006457; GO:0007186; GO:0016020; GO:0031982; GO:0032991; GO:0043209; GO:0044297; GO:0044877; GO:0048471; GO:0051020; GO:0070062,0.004557893,1.00E-07,1.00E-07,0.032315851,0.020834908,0.034022147,0.032315851,-4.951614209,0.027538271,0.0152885,6.487127797,0.002223036,0.030253086,-4.509721208,37331,1.51923032,3,2,0,1.00E-07,0.032315851,323158.5094,18.30188246,-4.951614209,-5.584853465,-4.877382023,1
O75127,PTCD1,PTCD1_HUMAN,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tRNA 3'-end processing [GO:0042780],"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:19651879, ECO:0000269|PubMed:21857155}. Mitochondrion matrix {ECO:0000250}.","Pentatricopeptide repeat-containing protein 1, mitochondrial",GO:0000049; GO:0003723; GO:0005739; GO:0005759; GO:0042780,1.00E-07,1.00E-07,1.63E-06,0.115959176,0.153803346,0.087840328,0.115959176,-3.10831111,0.119200339,0.059600781,6.48117745,0.002231168,0.030315557,-4.514147351,78856,1.518334441,4,2,0,1.00E-07,0.115959176,1159591.759,20.14518555,-3.10831111,-2.700841206,-3.508972747,1
Q9NVN3,RIC8B,RIC8B_HUMAN,cell cortex [GO:0005938]; centrosome [GO:0005813]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of G-protein coupled receptor protein signaling pathway [GO:0008277],"SUBCELLULAR LOCATION: Cytoplasm, cell cortex {ECO:0000269|PubMed:12652642}. Note=Localizes to the cell cortex.",Synembryn-B (Brain synembryn) (hSyn) (Protein Ric-8B),GO:0001965; GO:0005085; GO:0005096; GO:0005813; GO:0005829; GO:0005886; GO:0005938; GO:0008277,0.007430143,7.35E-05,8.09E-05,0.029253457,0.043735097,0.030838101,0.030838101,-5.019142268,0.032080701,0.018568534,6.410376563,0.002330751,0.031320605,-4.567067319,58825,1.504169857,5,0,0,8.09E-05,0.030838101,381.3328014,8.574906824,-5.095249081,-4.515064691,-5.019142268,1
Q92871,PMM1,PMM1_HUMAN,cytosol [GO:0005829]; neuronal cell body [GO:0043025]; metal ion binding [GO:0046872]; phosphomannomutase activity [GO:0004615]; cellular response to leukemia inhibitory factor [GO:1990830]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047],SUBCELLULAR LOCATION: Cytoplasm.,Phosphomannomutase 1 (PMM 1) (EC 5.4.2.8) (PMMH-22),GO:0004615; GO:0005829; GO:0006013; GO:0006487; GO:0009298; GO:0043025; GO:0045047; GO:0046872; GO:1990830,1.00E-07,1.00E-07,1.00E-07,0.026247241,0.026126178,0.041449289,0.026247241,-5.251690429,0.031274136,0.015637168,6.387019749,0.002364778,0.031678408,-4.584629264,29747,1.499236657,5,3,0,1.00E-07,0.026247241,262472.4064,18.00180624,-5.251690429,-5.258360121,-4.59250882,1
Q12974,PTP4A2,TP4A2_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; prenylated protein tyrosine phosphatase activity [GO:0004727]; post-translational protein modification [GO:0043687],SUBCELLULAR LOCATION: Cell membrane. Early endosome. Cytoplasm.,Protein tyrosine phosphatase type IVA 2 (EC 3.1.3.48) (HU-PP-1) (OV-1) (PTP(CAAXII)) (Protein-tyrosine phosphatase 4a2) (Protein-tyrosine phosphatase of regenerating liver 2) (PRL-2),GO:0004727; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0043687,5.68E-05,0.006883743,0.000113737,0.026883991,0.029277485,0.01935652,0.026883991,-5.217108878,0.022821232,0.013762049,6.321204788,0.002463951,0.032511951,-4.634396014,19127,1.487956962,5,0,0,0.000113737,0.026883991,236.3689421,7.884896673,-5.217108878,-5.094064568,-5.691036617,1
Q96IG2,FBXL20,FXL20_HUMAN,cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like),GO:0000209; GO:0001662; GO:0004842; GO:0005829; GO:0043687,7.09E-05,5.39E-05,7.65E-05,0.045551009,0.048820116,0.075029562,0.048820116,-4.356380458,0.056399776,0.028267008,6.281763987,0.002525798,0.033211719,-4.664419971,48423,1.478708643,10,0,0,7.09E-05,0.048820116,688.4419167,9.42719113,-4.456373184,-4.356380458,-3.736397053,1
O43252,PAPSS1,PAPS1_HUMAN,cytosol [GO:0005829]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103],,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],GO:0000103; GO:0001501; GO:0004020; GO:0004781; GO:0005524; GO:0005829; GO:0016779; GO:0042803; GO:0050428,2.40E-05,1.97E-05,3.43E-05,0.13935021,0.134106926,0.078592275,0.134106926,-2.898544352,0.11732379,0.058687908,6.271817211,0.002541691,0.033267395,-4.672015769,70833,1.477981206,11,0,0,2.40E-05,0.134106926,5598.385156,12.45079503,-2.843212914,-2.898544352,-3.669468682,1
Q6ZN54,DEF8,DEFI8_HUMAN,intracellular [GO:0005622]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029],,Differentially expressed in FDCP 8 homolog (DEF-8),GO:0005622; GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029,0.10264443,0.118895681,0.177179591,0.384705437,0.358565656,0.492047097,0.384705437,-1.378173877,0.278866163,0.272339649,6.206208321,0.002649613,0.034106292,-4.722360846,58710,1.467165495,4,0,0,0.118895681,0.384705437,3.235655262,1.694057906,-1.378173877,-1.479690783,-1.023131683,1
Q9H2C0,GAN,GAN_HUMAN,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeleton organization [GO:0007010]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567],"SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton.",Gigaxonin (Kelch-like protein 16),GO:0005737; GO:0005829; GO:0005856; GO:0007010; GO:0016567; GO:0031463; GO:0043687,1.00E-07,1.00E-07,1.23E-06,0.067997179,0.056265004,0.037019416,0.056265004,-4.151618327,0.053760056,0.026880505,6.186301829,0.002683449,0.034438263,-4.737720223,67638,1.462958766,17,2,0,1.00E-07,0.056265004,562650.0385,19.10187834,-3.878381301,-4.151618327,-4.755574068,1
Q5RI15,COX20,COX20_HUMAN,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial respiratory chain complex IV assembly [GO:0033617],"SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:23125284, ECO:0000269|PubMed:29154948}; Multi-pass membrane protein {ECO:0000255}.","Cytochrome c oxidase assembly protein COX20, mitochondrial",GO:0005739; GO:0005743; GO:0009060; GO:0016021; GO:0033617,1.00E-07,7.21E-05,1.00E-07,0.053190362,0.05299111,0.03018643,0.05299111,-4.23810584,0.045431879,0.022740028,6.182935248,0.002689223,0.034460698,-4.740321693,13291,1.462675933,3,2,0,1.00E-07,0.05299111,529911.1006,19.01539082,-4.232691327,-4.23810584,-5.049956035,1
P18433,PTPRA,PTPRA_HUMAN,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165],SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48),GO:0000165; GO:0004725; GO:0005001; GO:0005088; GO:0005622; GO:0005886; GO:0005887; GO:0007411; GO:0008286; GO:0043235; GO:0070062,3.67E-05,4.91E-05,4.36E-05,0.184406934,0.111181413,0.117979206,0.117979206,-3.083395486,0.137812716,0.068949493,6.130644025,0.002780866,0.035139521,-4.780874377,90719,1.454204157,14,0,0,4.36E-05,0.117979206,2704.060165,11.40091154,-2.43903519,-3.16901247,-3.083395486,1
Q9P2R6,RERE,RERE_HUMAN,"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; poly-glutamine tract binding [GO:0008267]; RNA polymerase II transcription coactivator activity [GO:0001105]; RNA polymerase II transcription corepressor activity [GO:0001106]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; NLS-bearing protein import into nucleus [GO:0006607]; radial glia guided migration of Purkinje cell [GO:0021942]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00512, ECO:0000255|PROSITE-ProRule:PRU00624, ECO:0000269|PubMed:10814707, ECO:0000269|PubMed:11331249}. Note=Localized in nuclear bodies of variables size. Colocalized with PML and BAX in nuclear PODs.",Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein),GO:0000118; GO:0000981; GO:0001105; GO:0001106; GO:0003682; GO:0005634; GO:0006338; GO:0006607; GO:0008267; GO:0008270; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813,1.00E-07,1.00E-07,1.00E-07,0.151462279,0.170462714,0.258139285,0.170462714,-2.552471891,0.193354659,0.09667743,6.115473486,0.002808158,0.035210478,-4.792690803,172424,1.453328075,6,3,0,1.00E-07,0.170462714,1704627.136,20.70102477,-2.722969549,-2.552471891,-1.95377838,1
Q9Y6I4,USP3,UBP3_HUMAN,"cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17980597}. Note=Localizes preferentially with monoubiquitinated H2A to chromatin.,Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3),GO:0000122; GO:0000278; GO:0000790; GO:0000978; GO:0004843; GO:0005634; GO:0005654; GO:0006281; GO:0006355; GO:0006511; GO:0008270; GO:0016578; GO:0016579; GO:0031647; GO:0036459; GO:0036464; GO:0042393; GO:0090543; GO:1990841,3.42E-05,4.35E-05,1.89E-05,0.051859669,0.050213411,0.028670172,0.050213411,-4.315783458,0.043548853,0.021806658,6.057112167,0.002916217,0.035954461,-4.838366407,58897,1.444247215,5,0,0,3.42E-05,0.050213411,1466.285989,10.5179508,-4.269243188,-4.315783458,-5.124305633,1
Q86TP1,PRUNE1,PRUN1_HUMAN,cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767],"SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cell junction, focal adhesion. Note=In some transfected cells a nuclear staining is also observed.",Exopolyphosphatase PRUNE1 (EC 3.6.1.1) (Drosophila-related expressed sequence 17) (DRES-17) (DRES17) (HTcD37) (Protein prune homolog 1) (hPrune),GO:0004427; GO:0005634; GO:0005829; GO:0005925; GO:0015631; GO:0016791; GO:0031113; GO:0046872; GO:0050767,1.00E-07,1.00E-07,1.00E-07,0.045962794,0.04267473,0.02502619,0.04267473,-4.550474175,0.037887805,0.018944002,6.056067698,0.002918196,0.035954461,-4.839187008,50200,1.444247215,10,3,0,1.00E-07,0.04267473,426747.2969,18.70302249,-4.443389686,-4.550474175,-5.320417535,1
Q8N6N2,TTC9B,TTC9B_HUMAN,,,Tetratricopeptide repeat protein 9B (TPR repeat protein 9B),,0.006276074,0.008963245,0.009889896,0.112299225,0.064985007,0.087416757,0.087416757,-3.515946336,0.079857258,0.048305034,6.05354871,0.002922977,0.035954461,-4.841166545,25932,1.444247215,3,0,0,0.008963245,0.087416757,9.752802615,3.285816859,-3.154580125,-3.943749293,-3.515946336,1
P30086,PEBP1,PEBP1_HUMAN,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; phosphatidylethanolamine binding [GO:0008429]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; serine-type endopeptidase inhibitor activity [GO:0004867]; MAPK cascade [GO:0000165],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,Phosphatidylethanolamine-binding protein 1 (PEBP-1) (HCNPpp) (Neuropolypeptide h3) (Prostatic-binding protein) (Raf kinase inhibitor protein) (RKIP) [Cleaved into: Hippocampal cholinergic neurostimulating peptide (HCNP)],GO:0000165; GO:0003723; GO:0004867; GO:0005524; GO:0005634; GO:0005829; GO:0008429; GO:0019899; GO:0019901; GO:0070062,0.000124628,0.000288275,4.19E-05,0.003480886,0.003087669,0.001967686,0.003087669,-8.339265973,0.002693824,0.001498502,6.053325763,0.0029234,0.035954461,-4.841341778,21057,1.444247215,12,0,0,0.000124628,0.003087669,24.77510214,4.6308191,-8.16632957,-8.339265973,-8.989284054,1
Q3YEC7,RABL6,RABL6_HUMAN,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],SUBCELLULAR LOCATION: Isoform 1: Cytoplasm {ECO:0000269|PubMed:17962191}. Note=Predominantly cytoplasmic (PubMed:17962191).; SUBCELLULAR LOCATION: Isoform 3: Nucleus {ECO:0000269|PubMed:17962191}. Note=Predominantly nuclear (PubMed:17962191).,Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1),GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829,1.00E-07,0.004499346,1.00E-07,0.021027677,0.022635483,0.013982874,0.021027677,-5.571566681,0.017715496,0.010357597,6.032219903,0.002963833,0.036347294,-4.857953799,79549,1.439527912,17,2,0,1.00E-07,0.021027677,210276.7743,17.68192998,-5.571566681,-5.465270084,-6.160195261,1
Q2KHT3,CLEC16A,CL16A_HUMAN,cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TORC1 signaling [GO:1904263],SUBCELLULAR LOCATION: Endosome membrane {ECO:0000250|UniProtKB:Q80U30}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q80U30}. Lysosome membrane {ECO:0000250|UniProtKB:Q80U30}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q80U30}. Note=Associates with the endolysosome membrane. {ECO:0000250|UniProtKB:Q80U30}.,Protein CLEC16A (C-type lectin domain family 16 member A),GO:0005794; GO:0005829; GO:0006914; GO:0009267; GO:0031982; GO:0032435; GO:0036020; GO:1901097; GO:1901098; GO:1901525; GO:1904263; GO:1904766,0.051565503,0.047480569,0.070004274,0.200400746,0.202182749,0.13994372,0.200400746,-2.319040217,0.124492289,0.11859626,5.9896176,0.003047527,0.036890801,-4.891625178,117715,1.43308192,6,0,0,0.051565503,0.200400746,3.886333601,1.958409747,-2.319040217,-2.306268191,-2.83708135,1
P68106,FKBP1B,FKB1B_HUMAN,calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; calcium channel inhibitor activity [GO:0019855]; cyclic nucleotide binding [GO:0030551]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; signaling receptor binding [GO:0005102]; 'de novo' protein folding [GO:0006458]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; chaperone-mediated protein folding [GO:0061077]; insulin secretion [GO:0030073]; ion transmembrane transport [GO:0034220]; negative regulation of heart rate [GO:0010459]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neuronal action potential propagation [GO:0019227]; positive regulation of axon regeneration [GO:0048680]; positive regulation of sequestering of calcium ion [GO:0051284]; protein maturation by protein folding [GO:0022417]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to redox state [GO:0051775]; response to vitamin E [GO:0033197]; smooth muscle contraction [GO:0006939]; T cell proliferation [GO:0042098],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Sarcoplasmic reticulum {ECO:0000250}.,Peptidyl-prolyl cis-trans isomerase FKBP1B (PPIase FKBP1B) (EC 5.2.1.8) (12.6 kDa FK506-binding protein) (12.6 kDa FKBP) (FKBP-12.6) (FK506-binding protein 1B) (FKBP-1B) (Immunophilin FKBP12.6) (Rotamase) (h-FKBP-12),GO:0000413; GO:0003755; GO:0005102; GO:0005528; GO:0005737; GO:0005829; GO:0006458; GO:0006939; GO:0009749; GO:0010459; GO:0010880; GO:0010881; GO:0014808; GO:0016020; GO:0019227; GO:0019855; GO:0022417; GO:0030018; GO:0030073; GO:0030551; GO:0032515; GO:0033017; GO:0033197; GO:0034220; GO:0034704; GO:0035584; GO:0042026; GO:0042098; GO:0042542; GO:0044325; GO:0048680; GO:0051280; GO:0051284; GO:0051480; GO:0051775; GO:0060314; GO:0060315; GO:0061077; GO:0061179; GO:0086064; GO:1903779,0.004260736,1.00E-07,1.00E-07,0.084394908,0.078812653,0.046333483,0.078812653,-3.665428923,0.068426703,0.035633663,5.949205228,0.003129574,0.037625217,-4.923739963,11783,1.424520988,3,2,0,1.00E-07,0.078812653,788126.5303,19.58806774,-3.566700229,-3.665428923,-4.431801045,1
O94967,WDR47,WDR47_HUMAN,cytoplasm [GO:0005737]; microtubule [GO:0005874]; multicellular organism development [GO:0007275],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Note=Localization along microtubules is mediated by MAP1S. {ECO:0000250}.",WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin),GO:0005737; GO:0005874; GO:0007275,1.80E-05,2.18E-05,5.23E-05,0.004252807,0.004604383,0.002492745,0.004252807,-7.877368744,0.003752599,0.001907013,5.947031401,0.003134063,0.037626335,-4.925472291,101949,1.424508085,28,0,0,2.18E-05,0.004252807,195.2213396,7.608966952,-7.877368744,-7.762776288,-8.648048773,1
O60347,TBC1D12,TBC12_HUMAN,autophagosome [GO:0005776]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of autophagosome assembly [GO:2000785]; regulation of vesicle fusion [GO:0031338],,TBC1 domain family member 12,GO:0005096; GO:0005776; GO:0006886; GO:0017137; GO:0031338; GO:0055037; GO:0090630; GO:2000785,0.252426388,0.211223448,0.36634869,0.952062262,1.520152302,1.408066776,1.408066776,0.493715754,1.016760938,0.785046644,5.875717447,0.003285724,0.038740772,-4.982578707,85626,1.411831726,5,0,0,0.252426388,1.408066776,5.57812829,2.479781115,-0.070872171,0.604215873,0.493715754,1
P19388,POLR2E,RPAB1_HUMAN,"cytosol [GO:0005829]; DNA-directed RNA polymerase I complex [GO:0005736]; DNA-directed RNA polymerase II, core complex [GO:0005665]; DNA-directed RNA polymerase III complex [GO:0005666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9852112}.,"DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II 23 kDa polypeptide) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog) (XAP4)",GO:0000398; GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005829; GO:0006283; GO:0006361; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006383; GO:0008543; GO:0016032; GO:0016070; GO:0042795; GO:0045815; GO:0060964,1.00E-07,1.00E-07,1.00E-07,0.012799759,0.007894921,0.007659099,0.007894921,-6.984859386,0.00945116,0.00472568,5.857637728,0.003325574,0.038987313,-4.997142214,24551,1.409076697,3,3,0,1.00E-07,0.007894921,78949.21375,16.26863728,-6.287739522,-6.984859386,-7.028609677,1
Q5MIZ7,PPP4R3B,P4R3B_HUMAN,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]; regulation of lipid metabolic process [GO:0019216],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18487071}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:18487071}. Nucleus {ECO:0000269|PubMed:18487071}. Note=In interphase localized in the cytoplasm and (with higher levels) the nucleus. During metaphase located in pericentriolar regions.",Serine/threonine-protein phosphatase 4 regulatory subunit 3B (SMEK homolog 2),GO:0005654; GO:0005737; GO:0005813; GO:0006470; GO:0016607; GO:0019216; GO:0030289; GO:0045722,0.00738356,3.31E-05,2.26E-05,0.267847673,0.144544249,0.197067122,0.197067122,-2.343240991,0.200673253,0.102816388,5.823158831,0.003403199,0.039366732,-5.025012503,97458,1.404870639,4,0,0,3.31E-05,0.197067122,5957.015606,12.54037402,-1.900515335,-2.79041689,-2.343240991,1
P78559,MAP1A,MAP1A_HUMAN,axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendritic branch [GO:0044307]; dendritic shaft [GO:0043198]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; primary dendrite [GO:0150001]; actin binding [GO:0003779]; cytoskeletal adaptor activity [GO:0008093]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; anterograde axonal protein transport [GO:0099641]; associative learning [GO:0008306]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of synaptic plasticity [GO:0048167]; retrograde axonal protein transport [GO:0099642],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.",Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2],GO:0000226; GO:0003779; GO:0005198; GO:0005737; GO:0005874; GO:0005875; GO:0007613; GO:0008017; GO:0008093; GO:0008306; GO:0015631; GO:0030424; GO:0032435; GO:0043198; GO:0044307; GO:0048167; GO:0099641; GO:0099642; GO:0150001; GO:1903829; GO:1904115; GO:2000010,0.000220315,0.000248196,0.000186955,0.03427855,0.026359842,0.018059463,0.026359842,-5.245514481,0.02601413,0.013225553,5.772388209,0.003521527,0.040238183,-5.066285218,305485,1.395361641,46,0,0,0.000220315,0.026359842,119.6460231,6.902628634,-4.866550106,-5.245514481,-5.791101212,1
Q8IVL0,NAV3,NAV3_HUMAN,nuclear outer membrane [GO:0005640]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of invadopodium disassembly [GO:1905929]; positive regulation of microtubule polymerization [GO:0031116],SUBCELLULAR LOCATION: Nucleus outer membrane {ECO:0000250}.,Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1) (Steerin-3) (Unc-53 homolog 3) (unc53H3),GO:0005524; GO:0005640; GO:0007026; GO:0008017; GO:0030336; GO:0031116; GO:0032703; GO:1905929,0.000167255,0.000125183,7.51E-05,0.044735948,0.046082938,0.024701441,0.044735948,-4.482421598,0.038384271,0.01931464,5.768819421,0.00353003,0.040238183,-5.069196897,255648,1.395361641,19,0,0,0.000125183,0.044735948,357.3630565,8.481246689,-4.482421598,-4.439623506,-5.339261007,1
Q9Y2G0,EFR3B,EFR3B_HUMAN,cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25380825}; Lipid-anchor {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25380825}. Cytoplasm, cytosol {ECO:0000269|PubMed:25380825}. Note=Palmitoylation anchors the protein to the plasma membrane (PubMed:23229899, PubMed:25380825). A small amount is observed in the cytosol (PubMed:25380825). {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25380825}.",Protein EFR3 homolog B,GO:0005829; GO:0005886; GO:0046854; GO:0072659,0.003374793,0.009289273,0.006781706,0.039710905,0.060223149,0.070205205,0.060223149,-4.053538042,0.050231163,0.031597505,5.71153685,0.003669963,0.041172851,-5.116122887,92487,1.385389062,13,0,0,0.006781706,0.060223149,8.880236241,3.150598057,-4.654320935,-4.053538042,-3.832278185,1
O00487,PSMD14,PSDE_HUMAN,"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; endopeptidase activator activity [GO:0061133]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of proteasomal protein catabolic process [GO:0061136]; response to ethanol [GO:0045471]; ubiquitin-dependent protein catabolic process [GO:0006511]",,26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1),GO:0000502; GO:0000724; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006303; GO:0006511; GO:0008237; GO:0008541; GO:0016579; GO:0022624; GO:0031597; GO:0034774; GO:0036459; GO:0043312; GO:0043687; GO:0045471; GO:0046872; GO:0061133; GO:0061136; GO:0061578; GO:0070536; GO:0070628; GO:1904813,0.000295846,0.001179059,0.000582236,0.01700539,0.009424284,0.012263535,0.012263535,-6.349481267,0.012212023,0.006791725,5.697301015,0.003705772,0.041499607,-5.127840897,34577,1.381956013,5,0,0,0.000582236,0.012263535,21.06282792,4.396627242,-5.87786406,-6.729401264,-6.349481267,1
Q9UBB4,ATXN10,ATX10_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; protein homotrimerization [GO:0070207],"SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:16498633}.",Ataxin-10 (Brain protein E46 homolog) (Spinocerebellar ataxia type 10 protein),GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0007399; GO:0016020; GO:0019899; GO:0030425; GO:0031175; GO:0042802; GO:0043025; GO:0048471; GO:0060271; GO:0070207,1.00E-07,1.00E-07,1.00E-07,0.170227814,0.159131855,0.088557897,0.159131855,-2.651705436,0.139305755,0.069652978,5.659814871,0.003802101,0.041940705,-5.158804502,53489,1.377364271,18,3,0,1.00E-07,0.159131855,1591318.546,20.60179123,-2.554461309,-2.651705436,-3.497235234,1
P23443,RPS6KB1,KS6B1_HUMAN,cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import [GO:0044539]; long-term memory [GO:0007616]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; regulation of glucose import [GO:0046324]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to testosterone [GO:0033574]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929],"SUBCELLULAR LOCATION: Cell junction, synapse, synaptosome {ECO:0000250}. Mitochondrion outer membrane. Mitochondrion. Note=Colocalizes with URI1 at mitochondrion.; SUBCELLULAR LOCATION: Isoform Alpha I: Nucleus. Cytoplasm.; SUBCELLULAR LOCATION: Isoform Alpha II: Cytoplasm.",Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA),GO:0000082; GO:0001662; GO:0003009; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0007165; GO:0007281; GO:0007568; GO:0007584; GO:0007616; GO:0009408; GO:0009611; GO:0009612; GO:0009749; GO:0009986; GO:0014732; GO:0014878; GO:0014911; GO:0016301; GO:0016477; GO:0018105; GO:0030054; GO:0030165; GO:0031929; GO:0032496; GO:0032869; GO:0033574; GO:0033762; GO:0034612; GO:0042277; GO:0042802; GO:0043005; GO:0043066; GO:0043201; GO:0043491; GO:0044539; GO:0045202; GO:0045471; GO:0045727; GO:0045931; GO:0045948; GO:0046324; GO:0046627; GO:0048015; GO:0048471; GO:0048633; GO:0048661; GO:0051721; GO:0071346; GO:0071363; GO:0071549; GO:2001237,0.012826099,0.021018614,0.006961885,0.107390567,0.103528873,0.064205588,0.103528873,-3.271894924,0.078106143,0.052655271,5.641505191,0.003850249,0.042254019,-5.173985226,59140,1.374131972,4,0,0,0.012826099,0.103528873,8.07173518,3.012878843,-3.219060821,-3.271894924,-3.961157317,1
P62847,RPS24,RS24_HUMAN,"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation initiation factor binding [GO:0031369]; erythrocyte homeostasis [GO:0034101]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]",,40S ribosomal protein S24 (Small ribosomal subunit protein eS24),GO:0000184; GO:0000462; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005829; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0015935; GO:0016020; GO:0022627; GO:0031369; GO:0034101; GO:0042274,0.007645864,0.012643864,0.013475041,0.025019524,0.028183805,0.022002601,0.025019524,-5.320801832,0.013813721,0.018161783,5.629352503,0.003882613,0.042450824,-5.184081851,15423,1.37211388,5,0,0,0.012643864,0.025019524,1.978787865,0.984616957,-5.320801832,-5.148989786,-5.506182116,1
P62937,PPIA,PPIA_HUMAN,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]; entry into host cell [GO:0030260]; establishment of integrated proviral latency [GO:0075713]; fusion of virus membrane with host plasma membrane [GO:0019064]; interleukin-12-mediated signaling pathway [GO:0035722]; leukocyte migration [GO:0050900]; lipid particle organization [GO:0034389]; neutrophil degranulation [GO:0043312]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of viral genome replication [GO:0045069]; RNA-dependent DNA biosynthetic process [GO:0006278]; uncoating of virus [GO:0019061]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]; virion assembly [GO:0019068],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16527992}. Secreted {ECO:0000269|PubMed:16527992}. Note=Secretion occurs in response to oxidative stress in vascular smooth muscle through a vesicular secretory pathway that involves actin remodeling and myosin II activation, and mediates ERK1/2 activation.","Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]",GO:0000413; GO:0003723; GO:0003755; GO:0005576; GO:0005615; GO:0005634; GO:0005829; GO:0005925; GO:0006278; GO:0006457; GO:0016018; GO:0016020; GO:0019058; GO:0019061; GO:0019064; GO:0019068; GO:0019076; GO:0030260; GO:0031982; GO:0032991; GO:0034389; GO:0034774; GO:0035722; GO:0043312; GO:0045069; GO:0045070; GO:0046790; GO:0050714; GO:0050900; GO:0051082; GO:0070062; GO:0075713; GO:1904813,5.64E-05,6.96E-06,0.000457536,0.019740733,0.010131903,0.01696285,0.01696285,-5.881477576,0.0154382,0.007892729,5.610968314,0.003932198,0.042802745,-5.199387228,18012,1.368528382,10,0,0,5.64E-05,0.01696285,300.7993234,8.232657512,-5.662680643,-6.624951046,-5.881477576,1
P51148,RAB5C,RAB5C_HUMAN,azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; neutrophil degranulation [GO:0043312]; plasma membrane to endosome transport [GO:0048227]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Early endosome membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}. Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.,Ras-related protein Rab-5C (L1880) (RAB5L),GO:0003924; GO:0005525; GO:0005765; GO:0005768; GO:0005769; GO:0005811; GO:0005886; GO:0015031; GO:0019003; GO:0030100; GO:0030139; GO:0031901; GO:0035577; GO:0042470; GO:0043312; GO:0048227; GO:0070062,0.000181225,0.000119816,0.000187527,0.05250004,0.072021048,0.037521255,0.05250004,-4.251537668,0.053851259,0.027088485,5.602308721,0.003955819,0.042863046,-5.206609784,23483,1.367916965,6,0,0,0.000181225,0.05250004,289.6957729,8.178394823,-4.251537668,-3.795437589,-4.7361481,1
P62380,TBPL1,TBPL1_HUMAN,"cytoplasm [GO:0005737]; transcription factor TFIIA complex [GO:0005672]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription coactivator activity [GO:0003713]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; acrosome assembly [GO:0001675]; DNA-templated transcription, initiation [GO:0006352]; dTTP biosynthetic process [GO:0006235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.,TATA box-binding protein-like protein 1 (TBP-like protein 1) (21 kDa TBP-like protein) (Second TBP of unique DNA protein) (STUD) (TATA box-binding protein-related factor 2) (TBP-related factor 2) (TBP-like factor) (TBP-related protein),GO:0000978; GO:0000981; GO:0001077; GO:0001675; GO:0003713; GO:0005672; GO:0005737; GO:0006235; GO:0006352; GO:0006366; GO:0007289; GO:0045944,1.00E-07,1.00E-07,1.00E-07,0.081369012,0.094125991,0.047583686,0.081369012,-3.619376709,0.074359463,0.037179832,5.56463513,0.004060593,0.043666678,-5.238130308,20887,1.359849842,4,3,0,1.00E-07,0.081369012,813690.1244,19.63411996,-3.619376709,-3.409263038,-4.393389168,1
P62263,RPS14,RS14_HUMAN,"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]",,40S ribosomal protein S14 (Small ribosomal subunit protein uS11),GO:0000028; GO:0000122; GO:0000184; GO:0000462; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0022627; GO:0030218; GO:0030490; GO:0045182; GO:0048027; GO:0070062; GO:0070181,0.004962879,0.000452816,0.000317716,0.0446715,0.026225868,0.029240081,0.029240081,-5.095908894,0.031468013,0.017645143,5.529445862,0.004161494,0.044397236,-5.267718189,16273,1.352644064,7,0,0,0.000452816,0.029240081,64.57386486,6.012878472,-4.484501497,-5.252865685,-5.095908894,1
P78318,IGBP1,IGBP1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of dephosphorylation [GO:0035303]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.,Immunoglobulin-binding protein 1 (B-cell signal transduction molecule alpha 4) (Protein alpha-4) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit) (Renal carcinoma antigen NY-REN-16),GO:0000122; GO:0005737; GO:0005829; GO:0007165; GO:0019888; GO:0032873; GO:0034612; GO:0035303; GO:0042113; GO:0043154; GO:0051721; GO:0060632; GO:0070555,0.018672603,0.001277588,0.001082762,0.11158094,0.110019715,0.064225413,0.110019715,-3.184166022,0.088264371,0.05114317,5.528298739,0.004164834,0.044397236,-5.268685099,39222,1.352644064,12,0,0,0.001277588,0.110019715,86.11514565,6.428195091,-3.163837487,-3.184166022,-3.960711919,1
O15020,SPTBN2,SPTN2_HUMAN,apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; spectrin [GO:0008091]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; axon guidance [GO:0007411]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; ER to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; multicellular organism growth [GO:0035264]; synapse assembly [GO:0007416]; vesicle-mediated transport [GO:0016192],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cell cortex.","Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)",GO:0000165; GO:0003779; GO:0005088; GO:0005200; GO:0005543; GO:0005615; GO:0005829; GO:0006888; GO:0007411; GO:0007416; GO:0008091; GO:0016192; GO:0016324; GO:0019886; GO:0021692; GO:0030054; GO:0030534; GO:0035264; GO:0043025; GO:0045296; GO:0051693,1.00E-07,0.000105988,1.00E-07,0.032376324,0.041548847,0.020998117,0.032376324,-4.948917012,0.0316057,0.015838246,5.524917031,0.004174699,0.044407699,-5.271536419,271325,1.352541731,70,2,0,1.00E-07,0.032376324,323763.2368,18.30457965,-4.948917012,-4.58904775,-5.573596223,1
Q8NBJ7,SUMF2,SUMF2_HUMAN,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; metal ion binding [GO:0046872]; post-translational protein modification [GO:0043687],"SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:15708861, ECO:0000269|PubMed:15962010, ECO:0000269|PubMed:18266766}.",Inactive C-alpha-formylglycine-generating enzyme 2 (Paralog of formylglycine-generating enzyme) (pFGE) (Sulfatase-modifying factor 2),GO:0005783; GO:0005788; GO:0043687; GO:0046872,0.008101084,0.003972441,0.002044803,0.087035422,0.09388729,0.050386563,0.087035422,-3.522253523,0.072396982,0.0409046,5.52263236,0.004181379,0.044407699,-5.273463505,33843,1.352541731,7,0,0,0.003972441,0.087035422,21.90980686,4.453504861,-3.522253523,-3.412926329,-4.310817144,1
Q12923,PTPN13,PTN13_HUMAN,cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphatidylinositol biosynthetic process [GO:0006661]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:11356191}. Nucleus {ECO:0000269|PubMed:10826496, ECO:0000269|PubMed:11356191}. Cell projection, lamellipodium {ECO:0000269|PubMed:11356191}. Note=Colocalizes with F-actin (PubMed:10826496). Colocalizes with PKN2 in lamellipodia-like structure, regions of large actin turnover (PubMed:11356191). {ECO:0000269|PubMed:10826496, ECO:0000269|PubMed:11356191}.",Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1),GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0006470; GO:0006661; GO:0014066; GO:0030027; GO:0035335; GO:0036312; GO:0043005; GO:0044297; GO:0070062; GO:0071345,6.00E-05,8.89E-05,5.61E-05,0.024341546,0.012248023,0.019398672,0.019398672,-5.687898279,0.018594405,0.009365544,5.503265167,0.00423853,0.044651949,-5.289823559,276906,1.350159576,7,0,0,6.00E-05,0.019398672,323.5215992,8.337718224,-5.360435397,-6.351307349,-5.687898279,1
O96000,NDUFB10,NDUBA_HUMAN,"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]",SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305|PubMed:12611891}; Peripheral membrane protein {ECO:0000305}; Matrix side {ECO:0000305}.,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (Complex I-PDSW) (CI-PDSW) (NADH-ubiquinone oxidoreductase PDSW subunit),GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0032981,1.00E-07,0.000184671,1.00E-07,0.026231719,0.013165143,0.022922774,0.022922774,-5.447074558,0.020711588,0.010417418,5.485928249,0.004290489,0.044898026,-5.30450527,20777,1.34777275,6,2,0,1.00E-07,0.022922774,229227.7384,17.80642211,-5.252543821,-6.247133035,-5.447074558,1
Q13315,ATM,ATM_HUMAN,"cytoplasmic vesicle [GO:0031410]; DNA repair complex [GO:1990391]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to X-ray [GO:0071481]; determination of adult lifespan [GO:0008340]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA double-strand break processing [GO:0000729]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; histone phosphorylation [GO:0016572]; immunoglobulin production [GO:0002377]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic spindle assembly checkpoint [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to gamma radiation [GO:1905843]; regulation of cellular response to heat [GO:1900034]; regulation of microglial cell activation [GO:1903978]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; signal transduction involved in mitotic G2 DNA damage checkpoint [GO:0072434]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9050866, ECO:0000269|PubMed:9150358}. Cytoplasmic vesicle {ECO:0000269|PubMed:9050866, ECO:0000269|PubMed:9150358}. Note=Primarily nuclear. Found also in endocytic vesicles in association with beta-adaptin. {ECO:0000269|PubMed:9050866, ECO:0000269|PubMed:9150358}.",Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated),GO:0000723; GO:0000724; GO:0000729; GO:0001541; GO:0001666; GO:0001756; GO:0002331; GO:0002377; GO:0003677; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005819; GO:0006260; GO:0006281; GO:0006303; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0007050; GO:0007094; GO:0007131; GO:0007140; GO:0007143; GO:0007165; GO:0007420; GO:0007507; GO:0008340; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0016303; GO:0016572; GO:0018105; GO:0030889; GO:0031410; GO:0032210; GO:0032212; GO:0033129; GO:0033151; GO:0035264; GO:0036289; GO:0042159; GO:0042981; GO:0043065; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0046777; GO:0046983; GO:0047485; GO:0048538; GO:0048599; GO:0051402; GO:0071044; GO:0071480; GO:0071481; GO:0071500; GO:0072434; GO:0090399; GO:0097694; GO:0097695; GO:1900034; GO:1901796; GO:1903626; GO:1903978; GO:1904262; GO:1904354; GO:1904358; GO:1904884; GO:1905843; GO:1990391,0.000103752,9.52E-05,0.000105778,0.028308172,0.014625062,0.019888768,0.019888768,-5.651902313,0.020839083,0.010521126,5.433523641,0.00445228,0.045436301,-5.349096015,350687,1.342597036,31,0,0,0.000103752,0.019888768,191.6952648,7.582670891,-5.142637596,-6.095413455,-5.651902313,1
P16949,STMN1,STMN1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; membrane [GO:0016020]; microtubule [GO:0005874]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; axonogenesis [GO:0007409]; brain development [GO:0007420]; establishment of skin barrier [GO:0061436]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; microtubule depolymerization [GO:0007019]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; neuron projection development [GO:0031175]; positive regulation of cellular component movement [GO:0051272]; regulation of microtubule polymerization or depolymerization [GO:0031110]; response to virus [GO:0009615]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.",Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),GO:0000281; GO:0005622; GO:0005737; GO:0005829; GO:0005874; GO:0007019; GO:0007052; GO:0007165; GO:0007409; GO:0007420; GO:0009615; GO:0015631; GO:0016020; GO:0031110; GO:0031115; GO:0031175; GO:0035024; GO:0035556; GO:0043005; GO:0048012; GO:0051272; GO:0051497; GO:0061436; GO:0070062; GO:0070495; GO:1905098,0.001056235,0.001605501,0.000904581,0.027128795,0.02777545,0.014815583,0.027128795,-5.204031202,0.022051171,0.012214357,5.427049575,0.004472774,0.045436301,-5.354626995,17303,1.342597036,8,0,0,0.001056235,0.027128795,25.68443241,4.682822287,-5.204031202,-5.17004592,-6.076740791,1
Q14669,TRIP12,TRIPC_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],"SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:20208519}.",E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (E3 ubiquitin-protein ligase for Arf) (ULF) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006511; GO:0006974; GO:0016607; GO:0045995; GO:0046966; GO:0061630; GO:1901315; GO:2000780,1.00E-07,8.65E-05,1.00E-07,0.064707921,0.10217645,0.055771623,0.064707921,-3.949913857,0.074189753,0.037123788,5.423140795,0.004485202,0.045436301,-5.357968755,220434,1.342597036,26,2,0,1.00E-07,0.064707921,647079.2133,19.30358281,-3.949913857,-3.290865381,-4.164324929,1
Q96NI6,LRFN5,LRFN5_HUMAN,cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021],SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000305}.,Leucine-rich repeat and fibronectin type-III domain-containing protein 5,GO:0005615; GO:0009986; GO:0016021,3.77E-05,3.03E-05,3.01E-05,0.056356576,0.061709286,0.100718899,0.061709286,-4.018368581,0.072895558,0.036480475,5.417714222,0.004502526,0.045503685,-5.362611105,79445,1.341953436,8,0,0,3.03E-05,0.061709286,2035.970892,10.99150122,-4.14927224,-4.018368581,-3.311593677,1
Q8TB52,FBXO30,FBX30_HUMAN,cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209],,F-box only protein 30,GO:0000209; GO:0004842; GO:0005829; GO:0008270; GO:0043687; GO:0061630,0.038960362,0.077052518,0.051779233,0.110627684,0.131741027,0.125314273,0.125314273,-2.996377349,0.06663029,0.08924585,5.401884834,0.004553521,0.045727145,-5.376172676,82304,1.339825916,9,0,0,0.051779233,0.125314273,2.420164714,1.275105239,-3.176215642,-2.924223389,-2.996377349,1
O75376,NCOR1,NCOR1_HUMAN,"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; transcriptional repressor complex [GO:0017053]; histone deacetylase binding [GO:0042826]; ligand-dependent nuclear receptor binding [GO:0016922]; nuclear hormone receptor binding [GO:0035257]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; circadian rhythm [GO:0007623]; negative regulation of JNK cascade [GO:0046329]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of fatty acid transport [GO:2000191]; regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter [GO:0072362]; regulation of lipid metabolic process [GO:0019216]; regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter [GO:0072368]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00624}.,Nuclear receptor corepressor 1 (N-CoR) (N-CoR1),GO:0000122; GO:0000790; GO:0000981; GO:0001102; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0005876; GO:0006325; GO:0006366; GO:0007623; GO:0016020; GO:0016922; GO:0017053; GO:0019216; GO:0035257; GO:0042826; GO:0044212; GO:0046329; GO:0046966; GO:0051225; GO:0072362; GO:0072368; GO:1903799; GO:2000191,0.054698829,0.03367256,0.060737413,0.208050005,0.325454338,0.367950948,0.325454338,-1.61947295,0.250782163,0.175094015,5.37110631,0.00465468,0.046358433,-5.402626289,270210,1.333871257,19,0,0,0.054698829,0.325454338,5.949932429,2.572873284,-2.264997775,-1.61947295,-1.442414645,1
P48651,PTDSS1,PTSS1_HUMAN,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Note=Highly enriched in the mitochondria-associated membrane (MAM). {ECO:0000250}.,Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I),GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740,0.00671424,0.040419236,0.012331597,0.105342681,0.102034042,0.074283899,0.102034042,-3.292877524,0.074065183,0.056854283,5.36630363,0.004670707,0.046382839,-5.406764226,55528,1.333642672,5,0,0,0.012331597,0.102034042,8.274195544,3.048619053,-3.246838019,-3.292877524,-3.750806645,1
Q86XE3,MICU3,MICU3_HUMAN,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; mitochondrial calcium ion transmembrane transport [GO:0006851],SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}. Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,"Calcium uptake protein 3, mitochondrial (EF-hand domain-containing family member A2)",GO:0005509; GO:0005743; GO:0006851; GO:0016021,1.96E-05,1.91E-05,4.34E-06,0.01145454,0.023022462,0.021235365,0.021235365,-5.557387304,0.018556435,0.009292571,5.362401252,0.00468378,0.046457884,-5.410128488,60711,1.33294057,5,0,0,1.91E-05,0.021235365,1111.436552,10.11820988,-6.447936646,-5.44081409,-5.557387304,1
Q9Y6M1,IGF2BP2,IF2B2_HUMAN,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; anatomical structure morphogenesis [GO:0009653]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; regulation of cytokine biosynthetic process [GO:0042035]; regulation of mRNA stability [GO:0043488],"SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Localizes at the connecting piece and the tail of the spermatozoa. In response to cellular stress, such as oxidative stress, recruited to stress granules.",Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0009653; GO:0017148; GO:0042035; GO:0043488; GO:0045182; GO:0048027; GO:0051028,0.005843158,0.00284555,0.002044706,0.029776651,0.033821914,0.018782813,0.029776651,-5.069674686,0.023882655,0.015519132,5.348487002,0.00473075,0.04659979,-5.422138782,66121,1.331616037,14,0,0,0.00284555,0.029776651,10.46428844,3.387402308,-5.069674686,-4.885897883,-5.73444302,1
Q9ULV4,CORO1C,COR1C_HUMAN,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; establishment of protein localization [GO:0045184]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12377779}. Cell projection, lamellipodium {ECO:0000269|PubMed:12377779}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:12377779}. Note=All isoforms localize in a diffuse and punctate pattern in the cytosol and are highly enriched in F-actin-rich areas. Isoform 3 colocalizes with the thin filaments of the sarcomere and with the postsynaptic area and the junctional sarcoplasm of motor end plates.",Coronin-1C (Coronin-3) (hCRNN4),GO:0001755; GO:0001932; GO:0001933; GO:0005737; GO:0005925; GO:0006909; GO:0007165; GO:0010632; GO:0010633; GO:0010762; GO:0015629; GO:0016328; GO:0016600; GO:0030027; GO:0030036; GO:0044387; GO:0045184; GO:0048365; GO:0051015; GO:0051893; GO:0051895; GO:0090630; GO:1900024; GO:1900025; GO:1900027; GO:2000394,1.00E-07,1.00E-07,7.25E-05,0.014250016,0.028563168,0.021010161,0.021010161,-5.572768991,0.021250229,0.010649334,5.340797119,0.004756952,0.04669668,-5.428786315,53249,1.330713992,9,2,0,1.00E-07,0.021010161,210101.6073,17.68072767,-6.132892628,-5.12970018,-5.572768991,1
P00367,GLUD1,DHE3_HUMAN,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; cellular amino acid biosynthetic process [GO:0008652]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350],SUBCELLULAR LOCATION: Mitochondrion matrix.,"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3)",GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006537; GO:0006538; GO:0006541; GO:0008652; GO:0021762; GO:0032024; GO:0042802; GO:0043531; GO:0070403; GO:0070728; GO:0072350,0.002204174,0.001007961,0.001009469,0.011574765,0.009778966,0.006496227,0.009778966,-6.676102425,0.007876118,0.00534526,5.31319339,0.004852456,0.047250654,-5.45270663,61398,1.325592176,8,0,0,0.001009469,0.009778966,9.687236985,3.276085236,-6.43287327,-6.676102425,-7.266182238,1
P21953,BCKDHB,ODBB_HUMAN,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; branched-chain amino acid catabolic process [GO:0009083],SUBCELLULAR LOCATION: Mitochondrion matrix.,"2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain) (BCKDE1B) (BCKDH E1-beta)",GO:0003826; GO:0003863; GO:0005739; GO:0005759; GO:0005947; GO:0009083,0.002506446,7.54E-05,9.39E-05,0.025153873,0.050347312,0.039984706,0.039984706,-4.644407895,0.037603403,0.019693595,5.312231171,0.004855827,0.047250654,-5.453542098,43122,1.325592176,5,0,0,9.39E-05,0.039984706,426.0098186,8.734742872,-5.313075653,-4.311941441,-4.644407895,1
Q9ULI0,ATAD2B,ATD2B_HUMAN,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24561620}. Note=Partially localizes to replication sites.,ATPase family AAA domain-containing protein 2B,GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0016887; GO:0031936; GO:0045944; GO:0070577,0.000281376,0.000477612,0.000254159,0.019619353,0.009703444,0.016281153,0.016281153,-5.940653344,0.014863601,0.007769516,5.299571557,0.004900435,0.047452176,-5.464544454,164914,1.323743867,16,0,0,0.000281376,0.016281153,57.86270713,5.854561917,-5.671578696,-6.687287414,-5.940653344,1
O75970,MPDZ,MPDZ_HUMAN,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; viral process [GO:0016032],"SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein; Cytoplasmic side. Apical cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density. Cell projection, dendrite. Cell junction, tight junction. Cell junction, synapse. Cell junction, synapse, synaptosome. Note=Associated with membranes. Colocalizes with HTR2C on the apical membrane of epithelial choroid plexus cells. Highly enriched in postsynaptic densities (PSD). Localized to punctae on dendrites of hippocampal neurons and colocalizes with the synaptic marker DLG4. Localized mainly in the Schmidt-Lanterman incisures of myelinating Schwann cells (By similarity). In the retina, localizes to the sub-apical region adjacent to the adherens junction complex at the outer limiting membrane. Enriched at the tight junctions of epithelial cells. Association to the tight junctions depends on CXADR. {ECO:0000250}.",Multiple PDZ domain protein (Multi-PDZ domain protein 1),GO:0005737; GO:0005923; GO:0007155; GO:0008022; GO:0014069; GO:0016032; GO:0016324; GO:0016327; GO:0030425; GO:0031410; GO:0043220; GO:0045211,0.000162576,6.55E-05,7.19E-05,0.039741669,0.019809852,0.037937178,0.037937178,-4.720243812,0.032396271,0.016298098,5.288856232,0.004938578,0.047532913,-5.473872122,221618,1.323005573,3,0,0,7.19E-05,0.037937178,527.9650496,9.044298619,-4.653203725,-5.657638095,-4.720243812,1
Q9UNH7,SNX6,SNX6_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of membrane [GO:0019898]; intracellular [GO:0005622]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle organization [GO:0016050]","SUBCELLULAR LOCATION: Early endosome {ECO:0000269|PubMed:11485546, ECO:0000269|PubMed:17148574, ECO:0000269|PubMed:19935774}. Early endosome membrane {ECO:0000269|PubMed:19935774, ECO:0000303|PubMed:11485546}; Peripheral membrane protein {ECO:0000269|PubMed:11485546}; Cytoplasmic side {ECO:0000305}. Cytoplasmic vesicle {ECO:0000269|PubMed:20354142}. Cytoplasm {ECO:0000269|PubMed:20830743}. Nucleus {ECO:0000269|PubMed:11591366, ECO:0000269|PubMed:20830743}. Note=Interaction with SNX1 or SNX2 promotes location at endosome membranes (PubMed:19935774). Only a minor proportion is seen in the nucleus. {ECO:0000269|PubMed:19935774}.","Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed]",GO:0005622; GO:0005634; GO:0005737; GO:0005829; GO:0006886; GO:0006897; GO:0007175; GO:0016050; GO:0016241; GO:0019898; GO:0030512; GO:0030904; GO:0030905; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0042803; GO:0045892; GO:0046982; GO:0097422,1.40E-05,8.20E-05,8.79E-05,0.030724631,0.020533445,0.015833521,0.020533445,-5.605880463,0.022302557,0.011212587,5.272379062,0.004997931,0.047773605,-5.488242505,46649,1.320811983,6,0,0,8.20E-05,0.020533445,250.2871334,7.967440318,-5.024460527,-5.605880463,-5.980874034,1
Q13242,SRSF9,SRSF9_HUMAN,"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA export from nucleus [GO:0006405]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10196175, ECO:0000269|PubMed:11694584, ECO:0000269|PubMed:12024014, ECO:0000269|PubMed:12604611}. Note=Cellular stresses such as heat shock may induce localization to discrete nuclear bodies termed SAM68 nuclear bodies (SNBs), HAP bodies, or stress bodies. Numerous splicing factors including SRSF1/SFRS1/SF2, SRSF7/SFRS7, SAFB and KHDRBS1/SAM68 accumulate at these structures, which may participate in the post-transcriptional regulation of mRNAs in stressed cells.","Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)",GO:0000398; GO:0003723; GO:0005654; GO:0005730; GO:0006376; GO:0006397; GO:0006405; GO:0006406; GO:0009636; GO:0019904; GO:0031124; GO:0043279; GO:0048025,1.07E-05,1.00E-07,1.00E-07,0.004791654,0.009082668,0.005808437,0.005808437,-7.427634233,0.006557274,0.003282283,5.258294703,0.005049346,0.047865338,-5.500552078,25542,1.31997887,10,2,0,1.00E-07,0.005808437,58084.37212,15.82586243,-7.705260634,-6.782668147,-7.427634233,1
Q8WVM7,STAG1,STAG1_HUMAN,"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; regulation of mitotic spindle assembly [GO:1901673]","SUBCELLULAR LOCATION: Nucleus. Chromosome. Chromosome, centromere. Note=Associates with chromatin. Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK1, except at centromeres, where cohesin complexes remain. At anaphase, the RAD21 subunit of cohesin is cleaved, leading to the dissociation of the complex from chromosomes, allowing chromosome separation.",Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1),GO:0000775; GO:0000785; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007049; GO:0007059; GO:0008278; GO:0016363; GO:0016604; GO:0051301; GO:0097431; GO:1901673,0.000138793,7.53E-05,5.73E-05,0.032934007,0.034052282,0.016923659,0.032934007,-4.924278156,0.027879509,0.014030228,5.235840157,0.005132638,0.048413865,-5.520226944,144427,1.315030243,15,0,0,7.53E-05,0.032934007,437.109912,8.771852283,-4.924278156,-4.876104687,-5.884814641,1
Q9Y2I8,WDR37,WDR37_HUMAN,"PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]",,WD repeat-containing protein 37,GO:0000460; GO:0000470; GO:0030687; GO:0070545,9.46E-05,6.95E-06,1.00E-07,0.016074522,0.015601353,0.027647282,0.016074522,-5.959080382,0.019740515,0.009904128,5.207055784,0.00524184,0.04877909,-5.545538062,54665,1.311766306,12,1,0,6.95E-06,0.016074522,2313.218828,11.17568603,-5.959080382,-6.002185011,-5.176718554,1
Q9BWD1,ACAT2,THIC_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629],SUBCELLULAR LOCATION: Cytoplasm.,"Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase)",GO:0003985; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006629; GO:0006635; GO:0006695; GO:0070062,1.00E-07,1.00E-07,1.00E-07,0.007956611,0.00988556,0.004734667,0.007956611,-6.973630249,0.007525513,0.003762856,5.201018461,0.005265097,0.048922788,-5.550859773,41351,1.310488803,10,3,0,1.00E-07,0.007956611,79566.10824,16.27986641,-6.973630249,-6.660461545,-7.722521316,1
Q15560,TCEA2,TCEA2_HUMAN,"transcription elongation factor complex [GO:0008023]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; DNA-templated transcription, elongation [GO:0006354]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription, elongation [GO:0032784]",SUBCELLULAR LOCATION: Nucleus.,Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l),GO:0003677; GO:0006354; GO:0008023; GO:0008270; GO:0032784; GO:0045944,6.94E-05,4.42E-05,0.077909765,0.328462217,0.381697126,0.212577766,0.328462217,-1.60620067,0.281571249,0.166793411,5.199882412,0.005269487,0.048922788,-5.551861665,33601,1.310488803,5,0,0,6.94E-05,0.328462217,4731.475452,12.20807443,-1.60620067,-1.389499771,-2.233937388,1
Q15650,TRIP4,TRIP4_HUMAN,"activating signal cointegrator 1 complex [GO:0099053]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; ligand-dependent nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription, DNA-templated [GO:0006355]; toxin transport [GO:1901998]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10454579, ECO:0000269|PubMed:12077347, ECO:0000269|PubMed:20873783, ECO:0000269|PubMed:26924529}. Cytoplasm, cytosol {ECO:0000269|PubMed:10454579, ECO:0000269|PubMed:20873783}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:20873783}. Note=Cytoplasmic under conditions of serum deprivation (PubMed:10454579). Colocalizes with NEK6 in the centrosome (PubMed:20873783). {ECO:0000269|PubMed:10454579, ECO:0000269|PubMed:20873783}.",Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4),GO:0002020; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0008270; GO:0016604; GO:0016922; GO:0019901; GO:0030331; GO:0030520; GO:0031594; GO:0032991; GO:0035035; GO:0044389; GO:0045661; GO:0045893; GO:0099053; GO:1901998,0.000179731,0.000382229,0.000324941,0.047747112,0.096117858,0.094301184,0.094301184,-3.406580301,0.079093085,0.039842176,5.191843329,0.00530068,0.049010239,-5.558955941,66146,1.309713183,4,0,0,0.000324941,0.094301184,290.2101074,8.180953956,-4.388442704,-3.379051687,-3.406580301,1
P55786,NPEPPS,PSA_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10978616}. Nucleus {ECO:0000305}.",Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S),GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955,1.00E-07,1.00E-07,1.00E-07,0.021382677,0.014951984,0.010555551,0.014951984,-6.063519225,0.015629971,0.007815085,5.165152869,0.005405847,0.049438085,-5.582566689,103276,1.305938359,20,3,0,1.00E-07,0.014951984,149519.8436,17.18997744,-5.547413736,-6.063519225,-6.5658543,1
Q9P2N5,RBM27,RBM27_HUMAN,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397],SUBCELLULAR LOCATION: Cytoplasm. Nucleus speckle. Note=Incorporated into the nuclear speckles and to speckles proximal to the nuclear periphery. Also localizes to punctate structures in the cytoplasm termed cytospeckles (By similarity). {ECO:0000250}.,RNA-binding protein 27 (RNA-binding motif protein 27),GO:0003723; GO:0005737; GO:0006397; GO:0016607; GO:0046872,1.00E-07,1.00E-07,1.00E-07,0.081548534,0.091044147,0.04346523,0.081548534,-3.616197254,0.072019203,0.036009702,5.147570341,0.005476497,0.049685558,-5.598168583,118718,1.303769824,5,3,0,1.00E-07,0.081548534,815485.3368,19.63729941,-3.616197254,-3.45728992,-4.523994411,1
Q8IZ21,PHACTR4,PHAR4_HUMAN,cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase activator activity [GO:0072542]; actin cytoskeleton organization [GO:0030036]; closure of optic fissure [GO:0061386]; enteric nervous system development [GO:0048484]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of catalytic activity [GO:0043085]; regulation of cell cycle [GO:0051726]; Rho protein signal transduction [GO:0007266],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell projection, lamellipodium {ECO:0000250}.",Phosphatase and actin regulator 4,GO:0001755; GO:0001843; GO:0003779; GO:0005737; GO:0007266; GO:0008157; GO:0030027; GO:0030036; GO:0043085; GO:0048484; GO:0051726; GO:0061386; GO:0072542; GO:2001045,0.000447533,0.000871078,0.004529861,0.061389458,0.032831949,0.040112301,0.040112301,-4.639811477,0.042828412,0.023363697,5.135819191,0.005524335,0.049838226,-5.608617393,78211,1.302437428,14,0,0,0.000871078,0.040112301,46.04900806,5.525098175,-4.025865246,-4.928755795,-4.639811477,1
Q9UID3,VPS51,VPS51_HUMAN,"cytosol [GO:0005829]; EARP complex [GO:1990745]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; autophagy [GO:0006914]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]","SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network {ECO:0000269|PubMed:20685960}. Recycling endosome {ECO:0000269|PubMed:25799061}. Note=Localizes to the trans-Golgi network as part of the GARP complex, while it localizes to recycling endosomes as part of the EARP complex (PubMed:25799061). {ECO:0000269|PubMed:25799061}.",Vacuolar protein sorting-associated protein 51 homolog (Another new gene 2 protein) (Protein fat-free homolog),GO:0000938; GO:0005730; GO:0005794; GO:0005829; GO:0006869; GO:0006914; GO:0007030; GO:0007041; GO:0015031; GO:0016020; GO:0016021; GO:0032456; GO:0032588; GO:0042147; GO:0043231; GO:0048193; GO:0055037; GO:1990745,7.62E-05,0.000120355,6.82E-05,0.056963094,0.040034979,0.027965333,0.040034979,-4.642595126,0.041566239,0.020871349,5.135585942,0.005525289,0.049838226,-5.608824965,86042,1.302437428,14,0,0,7.62E-05,0.040034979,525.5473557,9.037676957,-4.133828681,-4.642595126,-5.160216689,1